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Abstract

FABRICATION AND CHARACTERIZATION OF BIOACTIVE, COMPOSITE
ELECTROSPUN BONE TISSUE ENGINEERING SCAFFOLDS INTENDED FOR
CLEFT PALATE REPAIR
By Parthasarathy Annapillai Madurantakam, Ph.D
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy in Biomedical Engineering at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director: Gary L Bowlin, PhD
Professor, Biomedical Engineering

Tissue Engineering is a scientific discipline that aims to regenerate tissues and
organs that are diseased, lost or congenitally absent. It encompasses the use of suitable
synthetic equivalents of native extracellular matrix that may or may not be supplemented
with cells or relevant growth factors. Such scaffolds are designed to reside at the site of
implantation for a variable period of time during which they induce the regeneration of
native tissue. During this time, they also provide a template for new cells to attach,
infiltrate, differentiate into appropriate phenotype and eventually restore function of the
xii

concerned tissue. Among the factors that affect the outcome are the composition of
scaffold, methods of fabrication, bulk properties of the scaffold and topography and
architecture at the cellular level.
Bone is unique in the body in that it is one of the few tissues capable of complete
regeneration even in adults, as seen during fracture healing. However, certain conditions
(non-union of fractures, congenital and acquired bone deficiencies) exist in which the
regenerative capacities of bone are exceeded and appropriate intervention becomes
necessary. Current treatment options include autologous bone grafts harvested from iliac
crest or de-cellularized allografts or synthetic substitutes made from metals, ceramics and
polymers. However these options have serious limitations: while autografts are limited in
supply, necessitate second surgery and show inadequate vascularization, allografts can
transmit viral infections. Metals, ceramics and polymers are in essence structural
replacements without performing any biological function. Other problems associated with
these synthetic materials include adverse immune reactions, corrosion, stress-shielding and
secondary fractures due to inadequate osseo-integration. Bone tissue engineering is a
specialized field of research that provides an alternative strategy to repair bone defects by
exploiting the advances in engineering and better understanding of bone biology.
Scaffold-based tissue engineering approach is a promising field that involves
implantation of a biomaterial that is specifically matched in terms of biological and
material properties to the tissue it replaces. This study explores the feasibility of using
electrospinning as a potential fabrication strategy for bone tissue engineering applications,
more specifically intended for cleft palate repair. This model represents a congenital
xiii

deformity that affects both hard and soft tissues and presents unique challenges and
opportunities. Among the challenges are: the need for the implant allow growth of the most
complex areas of the facial skeleton, integrate and grow with the patient through
adolescence, the ability of the implant to not interfere with vital functions including
breathing and feeding. Further the implant should provide a flexible matrix that can
effectively support erupting teeth. In spite of these extreme demands, maxilla is a non loadbearing membranous bone, a favorable consideration from materials engineering
perspective.
The present study is organized into three independent sections. The first section
investigates developing strategies intended to improve the material properties of
electrospun bone scaffold. Bone is composed of a high volume fraction (50%) of inorganic
hydroxyapatite nanocrystals that is closely associated with collagen. The dispersal of
brittle mineral is critical in not only strengthening the bone in compression but also
contributes to the osteoconductivity of the matrix. Since loading of mineral in a bone
scaffold is a serious limitation, we attempted to achieve improved loading of bone mineral
by dual mineralization approach. We first incorporated nanocrystalline hydroxyapatite
(nHA) directly into the scaffold by adding it to the electrospinning polymer solution. The
second step involves inducing biomimetic mineralization of electrospun scaffolds by
incubating them in simulated body fluid (SBF) for 2 weeks. The hypothesis was that the
nanocrystalline hydroxyapatite seeded during electrospinning would act as sites for
nucleation and further crystal growth when incubated in solution supersaturated with
respect to calcium and phosphate ions. We tested this approach in two synthetic,
xiv

biocompatible polymers-polydioxanone and poly (lactide: glycolide) and four formulations
of SBF with differential loading of nHA (0-50% by wt. of polymer). A modified Alizarin
Red S (ARS) staining that specifically binds to calcium was developed that allowed us to
quantify the mineral content of 3D scaffold with great accuracy. Results indicated a unique
combination of factors: PDO scaffolds containing 50% nHA incubated in 1x revised-SBF
incubated under static conditions gave maximum mineralization over a period of two
weeks. We then sought to exploit these findings to engineer a stiffer scaffold by stacking
multiple layers together and cold welding them under high pressure. Electrospun scaffolds
(1, 2 or 4 layered stacks) were either compressed before or after mineralizing treatment
with SBF. After two weeks, scaffolds were analyzed for total mineral content and stiffness
by uniaxial tensile testing. Results indicated while compression of multiple layers
significantly increases the stiffness of scaffolds, it also had lower levels of mineralization
partly due to increased density of fibers and loss of surface area due to fiber welding.
However this can be offset to a reasonable degree by increasing the number of stacks and
hence this strategy can be successfully adopted to improve the mechanical properties of
electrospun scaffolds.
The second section introduces a novel infrared imaging technique to quantify and
characterize the biological activity of biomaterials, based on cell adhesion. Cells attach to
the surface by the formation of focal contacts where multiple proteins including vinculin
and talin assemble to signal critical processes like cell survival, migration, proliferation
and differentiation. After allowing MG-63 osteoblasts to adhere to 2D biomaterial surface
coated with extracellular matrix proteins (collagen, gelatin, fibronectin) cells were fixed
xv

and probed with antibodies for vinculin and talin. Secondary antibodies, tagged with
infrared-sensitive fluorescent dyes, were used to quantify the molecules of interest. In
addition, the kinetics of focal contact formation in these different substrates was followed.
Successful quantification of focal contacts were made and further research revealed
phosphorylation of vinculin at pY-822 as one potential mechanism for recruitment of
vinculin to focal contacts. Hence it could represent a subset of vinculin and might serve as
a specific molecular marker for focal contacts. As an extension, we evaluated the
possibility of using such an assay to quantify 3D electrospun tissue engineering scaffolds.
We fabricated scaffolds of graded biological activity by electrospinning blends of
polydioxanone and collagen in different ratios. Vinculin and talin expressed by MG-63
cultured on these scaffolds for 24 hours were quantified in a similar manner. Results
indicate that while talin does not show a significant difference in expression among
different scaffolds, vinculin showed a positive correlation with increasing biological
activity of scaffolds. In conclusion, we have identified vinculin as a reliable marker of
focal contacts in 3D scaffolds while phosphovinculin (pY-822) was more specific to focal
contacts in coated 2D substrates. In both instances, infrared imaging proved to be reliable
in study of focal contacts.
The third section aims to make the bone scaffolds osteoinductive- a property of a
material to induce new bone formation even when implanted in subcutaneous and
intramuscular heterotopic sites. Bone morphogenetic proteins (BMP) are potent cytokines
that can induce migration, proliferation and differentiation of stem cells along osteoblastic
lineage. The therapeutic efficacy of BMPs in the treatment of severe bone defects has been
xvi

identified and is currently FDA approved for specific orthopedic applications. BMPs are
clinically administered in a buffer form that not only makes the treatment expensive but
less effective. Suitable delivery systems for BMP delivery have been an intense area of
investigation. We rationalized electrospinning as a strategy to incorporate BMP within the
scaffold and that would enable controlled release when implanted. One of the drawbacks of
using electrospinning to deliver bioactive molecules is the potential denaturing effect and
eventual loss of activity of BMPs. The final section of this dissertation tries to develop
sensitive and relevant assays that could answer intriguing questions about solvent-protein
interaction. We chose to use the BMP-2/7 heterodimer as the osteoinductive molecule of
choice because of its superior potency compared to homodimer counterparts. We
characterized the detection and quantification of BMP-2/7 using a slot blot technique.
Further, we used a novel cell line (C2C12 BRA) to test the retention of activity of BMP2/7 that has been exposed to organic solvents. Results indicate significant loss of activity
when BMPs are exposed to organic solvents but complete recovery was possible by
diluting the solvent with an aqueous buffer.

xvii

Chapter 1: CLEFT PALATE - A CLINICAL NEED

1.1. INTRODUCTION
The face is one of the most complex parts of the human body from an anatomical
and functional perspective. The maxilla with the palate plays a significant role in
performing diverse functions like mastication, deglutition, respiration and speech. Given
such complex functional anatomy, even a slight aberration during gestation can jeopardize
the balance of normal craniofacial growth and development, as seen in craniofacial
syndromes. The most common of all craniofacial anomalies, and the second most common
of all birth defects, are clefts of the lip with or without cleft palate and cleft palate alone.
These anomalies occur at a rate of 1 out of 600 live births in Whites and 1 out of 850 live
births in African Americans, costing $176 million annually in direct medical costs alone
[1].
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Cleft palate arises from the failure of fusion of lateral palatal shelves with each
other and to the primary palate leading to alveolar and palatal bony deficiency. A bony
deficit at this structurally important area leads to collapse of the maxillary arch, distortion
of dento-alveolar segments and derangement of occlusion. It also opens up a permanent
communication between the mouth and nose leading to other associated complications.
Treatment of cleft palate is multi-disciplinary and involves specialized procedures from
birth to early adulthood in an established sequence. Definitive correction of palatal bone
deficit is carried out at 7-9 years of age and is called Secondary Alveolar Bone Grafting
(SABG). The reasons for bone grafting include: provide bony support to the teeth in line
with and adjacent to the cleft, establish maxillary arch continuity, enhancement of nasolabial contour and facial esthetics. Bone grafting also increases the chances of spontaneous
eruption of canines and ensures optimal bone support [2].
1. 2. CURRENT TREATMENT OPTIONS IN CLEFT PALATE REPAIR
The most preferred source of donor bone for secondary alveolar bone grafting is the
autologous cancellous bone from the iliac crest [3, 4]. In addition to being nonimmunogenic, autologous grafts are osteoconductive, osteoinductive and osteogenic and
hence are considered ‘gold’ standard for bone grafts [4]. However, the use of autologous
bone graft is associated with significant donor site morbidity including chronic pain [5],
infection, neurovascular injuries, iliac wing fractures, change in gait, deep hematoma
formation and scarring [6. 7]. Unpredictable resorption [8] and lack of mechanical strength
precludes their use as structural grafts. Allografts can be harvested from live donors
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(femoral heads during primary hip arthroplasty) or cadavers, processed and stored. They
are devoid of cells, primarily osteoconductive, exhibit slow vascularization, incomplete
incorporation and are susceptible to fatigue fracture [9, 10]. Allografts also carry the risk of
infection transfer and unfavorable immune reactions [9, 11].

These disadvantages

associated with sourcing natural bone tissue from humans highlight the need to develop
synthetic substitutes.
1. 3. BONE TISSUE ENGINEERING
Research to develop synthetic alternatives to bone has been along two divergent
directions- biomaterials approach resulting in a variety of ceramics, polymers, metals and
molecular biology approach involving the use of biological molecules and gene therapy
[12]. The limitations of either strategy to be successful in isolation call for an integrated
approach in the development of synthetic bone substitutes. Bone tissue engineering is an
emerging multi-disciplinary field in which synthetic or natural compounds are manipulated
to produce biologically based replacement tissues and organs [13]. It involves implantation
of three dimensional (3D) biodegradable matrices (scaffolds) that mimics the native
extracellular matrix (ECM) to guide tissue regeneration. These matrices can also be used to
deliver cells of interest to specific sites in high numbers to further accelerate healing. A
variety of synthetic and natural polymers that support cell infiltration and subsequent
replacement have been used as bone tissue constructs [14].

3

Chapter 2: NANOFIBROUS SCAFFOLDS AND TISSUE
ENGINEERING

Preface: The following chapter is compiled from two review articles published in
Nanomedicine, February 2009, Vol. 4, No. 2, pages 193-206
and
Polymer International, 2007, Vol. 56, pages 1349-1360.
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2. 1. ABSTRACT
Native extracellular matrix (ECM) provides structural support to the multi-cellular
organism on a macroscopic scale and establishes a unique microenvironment (niche) to
tissue and organ-specific cell types. Both these functions are critical for optimal function of
the organism. These natural ECM comprised predominantly of fibrillar proteins, collagen
and elastin, are synthesized as monomers but undergo hierarchical organization into well
defined nano-scaled structural units. The interaction between the cells and ECM is
dynamic, reciprocal and is essential for tissue development, maintenance of function,
repair and regeneration processes. Tissue engineering scaffolds are synthetic, biomimetic
ECM analogues that have shown great promise in regenerative medicine. Ongoing efforts
in mimicking the native ECM in terms of composition and dimension have resulted in
three strategies that permit generation of scaffolds in nanometer dimensions. While
excellent reviews regarding the applications of these strategies in tissue engineering are
available, a comprehensive review of the science behind these fabrication techniques do
not exist. This review intends to fill this critical gap in the existing knowledge in the fast
expanding field of nanofibrous scaffolds. A thorough understanding of the fabrication
processes would enable us better exploit available technologies to produce superior tissue
engineering scaffolds.

5

2. 2. INTRODUCTION
Multicellular organisms are characterized by complex 3D organizational network
of cells and their supporting matrices to form tissues and organs. In exception to the
circulatory cells, all other cell types are anchorage dependent for survival [15-17] and are
associated with its own unique microenvironment composed of extracellular matrix (ECM)
and interstitial fluid [18]. Cells are classified not only based on their function but also
according to their relation to the ECM. For example, epithelial cells are characterized by
minimal ECM, the basement membrane, while cells of connective tissue like bone,
cartilage, blood vessel and dermis is characterized by an abundance of ECM. In this
circumstance, the ECM is composed of specific elements that are structurally organized to
allow for a specific function. The dominant component of the ECM is structural proteinscollagen, elastin and reticular fibers. These structural proteins exhibit multiple levels of
organization. At the most fundamental level, they are synthesized as peptide monomers
that are then covalently crosslinked to form polymers. These polymers self assemble to
form fibrils and bundles of fibrils organize to form fibers. Further organization of fibers
into fascicles gives the ECM its unique form to optimally perform its function [19]. One
underlying theme in natural ECM is the organization of these proteins in the form of fibers
even at the ultra-structural level. This is in contrast to the globular structure of functional
proteins like enzymes and transport proteins. The ECM also binds to the dormant, inactive
forms of growth factors, activating and releasing them upon need thus acting as their local
reservoir. The organization of the natural ECM in the form of nanofibers not only provides
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steady anchorage to cells by binding to integrins but also activates intra-cellular signaling
pathways that ultimately affects almost all aspects of cell behavior [20]. The fibrous
architecture of native ECM also plays a very important role in mechanotransduction; it
deforms visco-elastically to external and internal stresses to keep the cells constantly
informed of the mechanical stresses [21-23]. The cells may respond to this change in stress
in a variety of ways including resorption of old ECM and laying down new matrix thus
redefining and remodeling its own niche. This dynamic reciprocity is pivotal to evolution
of multicellular organisms and its relevance cannot be overemphasized in normal processes
of growth, development and regeneration [24-27] and even in disease states [28]. Given
such physiological relevance, it comes as no surprise that a lot of effort have been invested
in mimicking the dimensions and composition of native ECM. The interdisciplinary fields
of tissue engineering and regenerative medicine have successfully identified three
fabrication strategies to generate nanofibrous scaffolds: self assembly, phase separation
and electrospinning. The application of these techniques in generating nanofibrous
scaffolds for a variety of applications have been extensively and exhaustively reviewed in
the literature [29-33]. This review attempts to demystify the science behind these
techniques with the idea that a better understanding of the process will result in better
control over the outcomes thus taking a step closer towards the goal of fabricating ideal
scaffolds.
It is the conscious effort on the part of authors to look beyond the arbitrary
boundaries separating the scientific disciplines into the more fundamental and universal
binding laws of science. Even though each of the three strategies discussed below-self
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assembly, phase separation and electrospinning might seem discrete and mutually
independent from each other from academic standpoint, the governing principles of
thermodynamics and equilibrium underlie these processes overlap. Infact, the phase
separation is a special case of self assembly that occurs under specific conditions.
2. 3. STRATEGIES FOR NANOFIBROUS SCAFFOLD FABRICATION
2. 3.1. Self Assembly
Self assembly is a bottoms-up fabrication strategy that permits generation of
defined 3D macroscopic structures from essentially uni-dimensional molecules.

It

involves autonomous organization of components into structurally well defined aggregates
and is driven towards the system’s thermodynamic minima resulting in stable and robust
structures [34]. These structures, stabilized by multiple, weak, non-covalent interactions,
can continue to expand to form ordered aggregates (irrespective of size scale) as long as
the formation of product is favorable and stable in a given set of conditions.
Self assembly offers certain advantages that are unique. Since the molecules
concerned interact at an atomic level driven by physical or chemical affinity, the sensitivity
and specificity of the entire process is increased. In addition, since the non-specific
interactions are energetically unfavorable, the system is robust and devoid of errors. In
addition, the atomic level interactions between components are retained throughout the
expansion process, thus providing a viable approach to retain nano-scale properties even in
bulk materials [35].
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Examples of molecular self assembly occur widely in biology and include
formation of lipid bi-layers, protein folding and DNA helices. Infact, molecular self
assembly is the most fundamental process of life and is the central phenomenon by which
all biological macromolecules assemble in a living cell. One of the best examples of self
assembly in biological systems directly relevant to tissue engineering is collagen.
Collagen refers to a diverse group of related proteins that share certain common
traits but also exhibit wide differences to fulfill functional demands of specific connective
tissue [36]. As a family, these proteins are made up of three polypeptide chains (α chains)
that have Gly-X-Y repeat sequences in the primary sequence, where X is mostly proline
and Y is mostly hydroxyproline. Current research indicates that at least 28 distinct types of
collagen trimers are assembled from as much as 43 distinct α chains [37]. Since type I
collagen is the most common type of fibrillar collagen and best understood, it will be used
as a model molecule in this review. Self assembly of collagen can be studied at two levels:
intracellular assembly of α chains into triple helical procollagen and extracellular assembly
of procollagen into fibrils [36,38].
Formation of procollagen: Collagen, like many other proteins, is translated, modified and
assembled in the rough endoplasmic reticulum. Type I collagen is a heterotrimer made of
α11 (1), α12 (1) and α2 (1) chains. Each α chain consists of a central collagenous domain
and terminal non-collagenous (NC) domains. Irrespective of the type of α chain, the central
collagenous domain, made of Gly-X-Y repeats, spontaneously folds into a left-handed
helix because of steric repulsion between proline residues in X position and
hydroxyproline residues in Y position. Selection of correct stoichimetry of α chains is
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important during assembly of trimeric procollagen molecule. Recent studies have shown
that this information resides in the chain recognition region, a variable sequence of 15
residues in C-terminal NC domain [38]. Once the appropriate α chains are identified the
polypeptides folds in a zipper-like fashion in the N terminal direction to form procollagen
molecule that exhibits a right-handed superhelical structure. This tertiary folding is
energetically favored because of lack of steric hindrances when the right-handed α helices
wind around the central axis formed by glycine residues [39].
Extracellular assembly into fibrils: The terminal NC domain of secreted procollagen
molecule is made up of a telopeptide and a propeptide sequence. Cleavage of C-terminal
propeptides by extracellular proteinases renders procollagen insoluble and triggers the
second phase of collagen self assembly: fibril formation. The insoluble tropocollagen
spontaneously aggregates with other tropocollagen monomers in a D-staggered
arrangement that results in axial growth of the fibril. Lateral and circumferential
association of multiple fibrils results in increase in fiber diameter. Variable kinetics of Nterminal proteinases in various types of collagen has been observed. The resulting
persistence of the N-propeptide on the surface has been implicated to sterically hinder
fibril incorporation to the center thus playing a role in limiting fibril growth and fiber
diameter [38].
Molecular self assembly, as an engineering strategy, refers to a biomimetic,
bottoms-up approach in biomaterial fabrication in which pure molecules interact with one
another in an aqueous environment to generate insoluble nanofibrous scaffolds stabilized
by non-covalent interactions. In one experiment, Yokoi et al. demonstrated spontaneous
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reassembly of synthetic peptides into nanofibers after all non-covalent interactions were
disrupted by sonication of the scaffold [40].Currently, self assembly in tissue engineering
is based on peptide-amphiphile (PA) or synthetic ionic peptide approaches.
Hartgerink et al. in a seminal paper [41] successfully engineered a synthetic bone
mimetic nanofibrous scaffold that is based on peptide-amphiphile (PA) (Figure 1). The
genius of this work lies in exploiting the basic tenets of biochemistry for applications in
tissue engineering. This PA consisted of an acyl tail that confers hydrophobicity, four
consecutive cysteine groups that would permit reversible crosslinking under appropriate
oxidation state, a flexible linker consisting of a series of glycine residues, a phosphorylated
serine residue to attract calcium ions and a cell recognition Arginine-Glycine-Aspartate
(RGD) motif. When a large number of synthetic PAs are allowed to interact in an aqueous
medium, the hydrophobic interaction drives the formation of fibrous network with the acyl
tails forming the core of the nanofiber. Adjusting the pH resulted in a stable cross-linked

A

B

C

Figure 1: Peptide-Amphiphile strategy for generation of mineralized nanofibers. A. Schematic of the
process of self assembled (PA). Hydrophobic aggregation of acyl chains in an aqueous environment
drives the assembly nanofibers with the polar groups facing the outside. B. Cryo-TEM image showing
a network of fibers with mean diameter of 7.1 nm in hydrated, native state. C. A 30 minute exposure of
PA fibers to calcium and phosphate reveal dense mineral deposition on the fibers. Electron diffraction
and energy dispersion X-ray spectroscopy (EDS) confirmed the mineral to be hydroxyapatite. (Jeffrey
D. Hartgerink, et al. Science 294, 1684, 2001. Reprinted with permission from AAAS)
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fibrous network and exposure to calcium resulted in formation of hydroxyapatite crystals
along the long axis of the fiber-an orientation that is similar to that of native collagen fiber.
Reversible assembly can be accomplished by change in pH or these thiol groups can be
permanently oxidized with iodine to lend stability to the nanofibrous structure through a
process called covalent capture.
In an interesting application of PAs, Silva et al. [42] mixed neural progenitor cell
suspensions with aqueous solutions of PAs containing the epitope of laminin. The
formation of 3D nanofibrillar network initiated upon mixing and the cells became
encapsulated within the fibrils. The authors not only demonstrated cell survival during this
process but also potency of laminin epitope on these progenitor cells in inducing neurite
formation. The progenitor cells differentiated into neurons very early (1 day) exhibiting
greater surface area than controls. More significant was the finding that astrocyte
differentiation is inhibited while neuronal phenotype is enhanced in cells grown in PA
network. This is exactly the opposite of controls where the astrocyte differentiation was a
dominant effect. These findings are important because inhibition of astrocyte proliferation
and prevention of glial scar is critical in neuronal regeneration following injury.
Zhang et al. exploited the inherent charge present in amino-acids to generate selfassembled peptide nanofibers [43-45]. He identified chemical complimentarity and
structural compatibility to be key requirements in assembly of nanofibers and
demonstrated self assembly of repetitive ionic self-complimentary peptide sequences
(including Arginine-Alanine-Asparatate, RAD) into a stable hydrogel composed of
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nanofibers. Furthermore, these peptides can be readily tailored with functional sequences
of collagen, laminin, fibronectin and osteopontin to enhance cell response [46] (Figure 2).
This approach is in contrast to peptide-amphiphile strategy adopted by Hartgerink
et al. where a combination of peptide and fatty acyl chain was used to drive self assembly.
One of attractive features of either of these two approaches is the use of pure biological
molecules as the building block of higher order structures and hence the concerns of
biocompatibility, toxicity and immune response are irrelevant [47]. Infact, there is

B

A

Figure 2: Self assembled nanofibrous scaffold based on ionic complimentarity of peptides. A. Cartoon
representation of the hierarchy in the self assembly of ionic self-complementary synthetic peptides with
functional group modification. The interaction between basic and acidic groups of the backbone drives
self assembly into the double β-sheet nanofiber with the functional domains projecting out for cell
interaction. Depending on the actual composition, they will then self assemble into a specific functional
3D scaffold. B. SEM of a self assembled nanofibrous scaffold. (Gelain et al. Macromolecular Bioscience,
7, 2007. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission)

evidence that the cells actively breakdown the nanofibers and internalize the fragments by
endocytosis and probably utilize these molecules for metabolism [48].
The application of self assembly scaffolds towards dental tissue regeneration has
been gaining popularity. Galler et al. [49] demonstrated biocompatibility and successful
remodeling of nanofibrous PA consisting of a MMP-2 cleavable sequence during culture
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with two different dental stem cells lines (SHED and DPSC). More interestingly, while
SHED cells exhibited much higher evidence of matrix deposition (collagen types I and III)
and remodeling (MMP-2), DHSC cells showed a significant increase in mineralization.
Kirkham et al. [50] evaluated the ability of self assembled anionic peptides to prevent and
/or reverse the effects of enamel demineralization under conditions mimicking the intraoral environment. Surface anionic peptide treatment not only significantly increased the
amount of new mineral deposited but also reduced the tendency of demineralization. The
finding is of therapeutic value because this can potentially be used to treat pre-cavitary
incipient caries (subsurface demineralization) and cases of enamel hypoplasia.
Collagen is the most abundant structural protein that consists of three left handed
helices wound together to form a right handed super-coiled super helix [51]. The ability of
collagen to spontaneously form triple helix is dictated largely by its primary amino acid
sequence with glycine at every third residue. While this smallest amino acid is buried in
the central core of the triple helix, the functional groups of adjacent amino acids project out
to the surface and participate in a large number of intra- and inter-molecular non-covalent
bonds (including hydrogen bonds) with solvent molecules. Since collagen is synthesized as
individual chains that spontaneously orient into a triple helix before further modification
and secretion, it provides a perfect paradigm to study self assembly of native ECM
proteins.
Gauba et al. [52,53] exploited the ionic interactions between oppositely charged
arginine and glutamate to induce self assembly of artificially synthesized peptides into
triple helical secondary structures resembling native collagen. They showed in their studies
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that while glutamine and arginine are inherently destabilizing to formation of triple helical
homotrimers, the same charged groups interacted favorably with each other to form
heterotrimers, when incorporated in different peptides. More recently, the same authors
[54] developed a successful strategy, based on molecular self assembly, to generate a
variety of triple helical structures that mimics normal or mutated collagen. These findings
are significant in that we could unearth some clues from nature as to what makes collagen
in certain disease states (mutations) more (hyperostosis) or less (fibrous dysplasia) prone to
undergo calcification. It would also be very exciting to see if such findings can be
exploited into generating matrices for appropriate applications (bone or blood vessel) in
tissue engineering.
More recently, Capito et al. [55] reported formation of macroscopic membranes at
the interface when solutions of hyaluronic acid and peptide-amphiphile are mixed. These
membranes are robust in both dry and hydrated state and are formed almost
instantaneously when two solutions with strong zeta potential (oppositely charged) are
brought into contact. An amorphous zone at the interface is formed within minutes due to
electrostatic complexation of counterions and rapid diffusion of small PAs interactions
through the hyaluronic acid layer. This creates a diffusion barrier that prevents random
mixing of the liquids. Subsequent reptation of the hyaluronic acid chains through the
diffusion barrier into the PA layer results in aggregation and eventual formation of PA
nanofibrils perpendicular to the interface. With time this growth of nanofibrous layer
increases in density and alignment.
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In addition to the exciting research discussed above, self assembly has shown
promise in neural tissue [47, 56], bone [57-61], vascular [62] engineering and controlled
release applications [63].
2. 3. 2. Phase Separation
A phase can be defined as a subset of macroscopic state of matter (solid, liquid or
gas) that is homogenous and has identical physical attributes and chemical composition.
However, multiple phases can coexist in equilibrium within any given state of matter.
Phase separation is a thermodynamic process that involves selective enrichment and
purification of the desired phase. The process of phase separation has been extensively
used in the fabrication of macroporous foams and membrane films and much of the
understanding comes from these sources. These concepts have been only recently been
applied in tissue engineering to generate nanofibrous scaffolds.
In order to better understand the concept of phase separation, polymers can be
compared to a bowl of spaghetti where individual polymer chains are randomly coiled and
entangled with neighboring chains. The shape and structural packing of the polymer chain
is dictated by a number of factors including: degree of polymerization, linearity of the
polymer chain, bulkiness and orientation of the pendant groups and the degree of
crystallinity of the polymer. Familiar forces like hydrogen bonding and van der Waals
forces play a very important role in stabilizing the secondary structure (folding and
crystallinity) of polymer chains, while mechanical entanglement of individual polymer
chains also contribute to the physical properties of the polymer.

16

When a polymer is dissolved in a solvent, much smaller solvent molecules
penetrate the tight network of polymer chains and disrupt the inter-chain forces. Slowly the
chains lose their dense packing and start to slide past each other with much more ease due
to disruption of stabilizing forces. This presents a network of ‘loosened’ and extended
polymer chains that enclose the solvent in the space separating the chains. Thus it is easy
to appreciate the presence of two phases in solution: a polymer rich phase containing the
chains and the solvent rich phase around and in between the chains. Controlled phase
separation involves selective enrichment of each of the phases throughout the solution that
would result in two separate phases or a single bi-continuous phase. Subsequent removal
of the solvent will result in generation of a porous structure containing loosely inter-twined
polymer chains. Based on the strategy used to induce phase separation and subsequent
removal of the solvent there are different variants of phase separation [64,65].
Solid and liquid models have been proposed to explain the concept of phase
separation of simple liquids and metals but both theories fall deficient when dealing with
colloidal or polymer solutions. Tanaka, in a series of papers [66-68], proposed a unifying
viscoelastic model to account for phase separation that occurs in polymer solutions and
suggested that solid and liquid models of phase separation as special cases. Unlike phase
separation of metals and simple liquids, polymer solutions exhibit two phases that are
distinctly different from each other with respect to molecular weight, glass transition
temperature, internal degrees of freedom and the ability to resist mechanical stress. Thus
these polymer solutions are said to exhibit ‘dynamic asymmetry’ between the phases and
the presence of this inherent asymmetric composition drives the separation of phases under
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appropriate conditions. In addition, the attractive forces between the polymer chains
overcomes the entropy of the system and leads to the formation of a transition gel networka hallmark of phase separation in polymer solutions. Eventually the phases separate and
phase inversion happens in which the polymer-rich phase forms the continuous phase and
solvent becomes the dispersed phase. The strategies employed to induce phase separation
for tissue engineering applications include non-solvent induced phase separation and
thermally induced phase separation which are discussed in detail below.
Non-solvent induced phase separation:
This process involves addition of a non-solvent to the polymer solution and subsequent
selective extraction and replacement of the solvent by non-solvent molecules. This would
result in a porous polymer structure that is stabilized in a solution of non-solvent.
Extrusion of collagen fibers: Although not traditionally classified under phase separation,

this is definitely a variant of non-solvent induced phase separation also called immersion
precipitation [69]. In this technique, collagen dissolved in acetic acid is extruded through
silicone tubing into a bath containing a non-solvent [70]. This results in exchange of acetic
acid for non-solvent and results in the formation of insoluble collagen fibers. Simultaneous
aggregation and self assembly of numerous fibrils result in formation of micron-sized
fibers. The rate of extrusion, pH and composition of the non-solvent are important
parameters in successful generation of continuous fibers. Even though this review is
primarily concerned with nanofibers, micron-sized collagen fiber generated by extrusion is
included because these threads are essentially aggregates of nano fibrils, just as they occur
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in the body [71]. Other examples of collagen fiber extrusion are listed for interested
readers [72-74].
Thermally Induced Phase Separation (TIPS):
Thermally Induced Gelation and Crystallization: Linear polymers in solution undergo a phase

transition from relatively low viscosity sol to an elastic gel over a narrow temperature
range on cooling. The gelation temperature depends on the polymer concentration and
characteristics of solvent itself. Gelatin forms a temperature dependent gel in water as a
function of concentration. Chain entanglement and inter chain attractive forces drive the
process of gelation. Removal of the solvent while preserving the structure of porous
polymer scaffold is a big challenge. In this regard, it was found that crystallization of the
polymer following gelation of the solution better preserves the architecture of the polymer
scaffold [64].
Thermally Induced Spinodal Decomposition: In contrast to controlled cooling of polymer

solutions in phase separation due to gelation/crystallization, thermally induced spinodal
decomposition involves rapid quenching of a homogenous polymer solution. This would
induce spontaneous phase separation of polymer solution into a polymer rich phase and a
solvent rich phase. It is well known that the quality of the solvent (the ability of the solvent
to dissolve a solute) decreases with temperature. So any lowering of temperature will result
in creation of unfavorable interface and thus phase separation. The driving force for phase
separation in TIPS is the decrease in the interfacial free energy between the polymer chains
and the solvent.
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The boundary of liquid-liquid demixing is called binodal. It is an equilibrium
boundary that demarcates stable phase separation and is established at infinitely slow rates
of cooling. In contrast, spinodal refers to unstable region bounded by the binodal that
captures phase separation of polymer solutions following quenching (instantaneous

Figure 3: A binary phase diagram showing the
boundary conditions of the phases of polymer
concentration as a function of temperature. Below a
critical temperature, homogenous solution begins to
phase separate and forms the binodal boundary under
equilibrium conditions. Enclosed within the binodal is
the spinodal that demarcates the phases that occur
due to rapid quenching. Depending on the initial
polymer concentration, different structures evolve
(polymer-dark, solvent-light): nucleation and growth of
polymer rich phase (left), solvent rich phase (right) or
spinodal decomposition resulting in a bicontinuous
structure which has interconnected polymer rich and
solvent rich phases. (Adapted from P. van de Witte et
al. Journal of Membrane Science, 1996)

cooling). The area between the spinodal and binodal is metastable and further demixing
occurs by nucleation and growth of either the polymer-rich or polymer-poor phase
depending on the initial polymer concentration (Figure 3).
Phase separation within the area enclosed by the spinodal occurs as a sinusoidal
wave progression throughout the solution instead of nucleation at discrete sites observed in
metastable areas of the phase diagram. This results in the formation of a bi-continuous
structure that has well interconnected but discretely enriched polymer-rich and polymerpoor phases [69]. Other factors that can play a role in phase separation of polymer
solutions include the degree of crystallinity, association of polymer chains at high
concentrations and their side groups.
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In tissue engineering applications, thermally induced phase separation by spinodal
decomposition has been the most promising strategy to generate porous 3D scaffolds. The
principles of TIPS in generating porous foams were cleverly exploited by Zhang and Ma to
generate fibrous scaffolds of aliphatic polyesters [75]. Their results were the first direct
evidence that spinodal decomposition following quenching is the most likely mechanism
for the formation of nanofibers because slow annealing caused crystal nucleation and
growth into platelet-like matrix. They identified gelation time, temperature and freezing
rate to be critical parameters in generation of the fibrous scaffold. The tendency of the
polymer to organize into nano-scaled fibers increased with the lower gelation temperature
and rapid quenching of the gel to -18°C for 10 minutes was sufficient for fiber formation.
Further the average fiber diameter did not change with increase in polymer concentration.
After phase-separation, an important processing step is the removal of the solvent
that would eventually result in the generation of porous scaffolds. The space occupied by
the solvent becomes the pores of the matrix. The ability to preserve the porous nanofibrillar structure during this critical processing step is a big challenge as the surface
tension of the evaporating solvent can exceed the rigidity of the matrix and cause it to
collapse. In addition if the temperature is not low enough, the polymer might re-dissolve
and can lead to loss of fibrillar architecture. Both these phenomena can happen with freeze
drying and contribute to a dense surface skin. In order to overcome these disadvantages of
freeze drying, Ho et al. [76] proposed freeze extraction as a technique to remove the
solvent without compromising the structural integrity of the matrix. The strategy employed
leaching the solvent for the non-solvent when the fibrillar polymer matrix is still frozen,
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thus making freeze drying unnecessary. Since solvent substitution occurs under frozen
conditions, there is no danger of polymer re-dissolving and subsequent structural collapse
when the temperature is raised. They also exploited the gelation tendency of alginate and
chitosan to generate nanofibrous scaffolds using the principles of freeze extraction.
Even though the science driving the process of phase separation is relatively well
understood, there has been relatively scanty evidence supporting the viability of this
technique in the generation of nano-fibrous scaffolds. Generation of porous foams is very
easy with this technique, but the real challenge is to identify the process parameters that
would consistently yield fibrous structures. Since this technique is simple and inexpensive,
such directed efforts will enable one to exploit this as a fabrication strategy to synthesize
fibrous scaffolds for tissue engineering applications.
2. 3. 3. Electrospinning
Electrospinning is a probably the most scalable and versatile strategy to generate
nanofibers among the currently available techniques. In this process, either a polymer melt
or solution is forced through a nozzle which under the influence of electric field produces a
non-woven mat made of sub-micron fibers (Figure 4A).
Doshi and Reneker [77], in their classic paper on electrospinning, held that
electrostatic charge accumulates on the pendant polymer drop and at a critical voltage
becomes sufficient to overcome the surface tension and a charged jet is drawn out from the
apex of Taylor cone. As the charged jet accelerates towards the collector plate under the
influence of electric field, solvent evaporates, fiber diameter thins and charge
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concentration occurs. This increase in charge density was presumed to cause enough
repulsion to actually lead to splitting of the primary jet into multiple filaments resulting in
a reduction of the fiber diameter with each split.

A

B

C

Figure 4: Electrospinning as a fabrication strategy for generating nanofibers. A. Schematic of
electrospinning setup. The polymer solution is pumped at a constant rate through a needle clamped to a
high voltage source. When the electric charge overcomes the surface tension of the liquid, a jet emanates
from the tip of Taylor cone and accelerates towards the target and is deposited as dry fibers. B.
Electrospun type I collagen scaffold showing random orientation of sub-micron fibers. C. TEM of the same
fibers showing characteristic 67 nm banding. Scale bar is 100 nm. (Reprinted from Barnes et al. in
Advanced Drug Delivery Reviews, 59 (14), 1413-33, Copyright (2007), with permission from Elsevier)

Current investigations into theoretical aspects of electrospinning reveal formation
of an inverted cone some distance away from the nozzle that represents the whipping
instability. Using high speed photography it was identified that the cone is actually a single
rapidly whipping jet [78] (Figure 5). The whipping frequency is high enough to confound
this process with splaying. Modern theories of electrospinning recognize at least three
possible types of instabilities that may contribute to the formation of the jet: Rayleigh
instability, conducting mode instability and whipping conducting mode instability [79,80].
While the first two modes are axisymmetric, whipping instability is non-axisymmetric.
Rayleigh instability is a direct result of surface tension, is dominant at lower electric fields
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and is suppressed with increasing field and surface charge density. Conducting mode
whipping instability arises due to interaction of higher surface charge with the external

A

B

C

Fig 5: High speed jet images of 2 wt % solution of PEO (MW 2,000,000) in water during
electrospinning. A. Stable jet at low field, high flow conditions (bar=55 mm). B. Unstable jet at
high field, low flow conditions (bar=55 mm, 1 ms exposure). C. Close-up of the onset of
instability (bar=51 mm, 18 ns exposure). Reused with permission from Shin et al. Applied
Physics Letters, 78, 1149 (2001). Copyright 2001, American Institute of Physics

electric field and dominates at higher potential. There exists a competition between these
different instabilities and the final morphology of collected fibers depends on the net
interaction. In fact, Zuo et al. [81] demonstrated that the formation of beads during
electrospinning is due to dominance of axisymmetric instabilities while whipping jet
instability has been attributed to the formation of smooth fibers. The whipping instability
has been proposed to account for the ability of electrospinning to reduce the millimeter
sized droplet to sub-micron sized fibers. They reason that this act of whipping greatly
enhances the distance that the jet travels before collecting on the mandrel leading to
increased stretch and splaying of smaller diameter fibers. The balance between the
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electrospinning can occur. Electrospinning of polycaprolactone from acetone was shown to
form loops, double loops and garland as a result of bending instability of the jet [82].
In addition, the formation of fibers depend on solution parameters (viscosity and
conductivity), process parameters (applied electric field and flow rate) and process
variables like

jet radius, axial velocity, charge distribution, and displacement of the

centerline of the jet as a function of the axial distance from the nozzle [78]. Chain
entanglements have been implicated as one critical parameter in influencing fiber
formation: continuous fibers cannot be generated from solutions that are dilute unentangled
or concentrated with tightly entangled polymer solutions [83].
In a recent article, He et al. [84] reviewed novel techniques expanded from
conventional electrospinning including siro-electrospinning, vibration electrospinning and
magnetic electrospinning to expand the versatility of conventional electrospinning to meet
new challenges. Hollow fibers having a core and sheath were generated using co-axial
electrospinning of two immiscible solutions by Li et al.[85]. More recently, the same
concept was expanded to generate continuous fibers of block copolymers that are
otherwise difficult to electrospin. The authors were able to control the diameter of the core
by adjusting the flow rates. Micro-phase separation was achieved by subjecting the as-spun
fiber to long term annealing. Higher glass transition temperature of the outer shell enabled
this process to occur because it provided a confined boundary for long range order of block
copolymer in the core [86].
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In yet another interesting variation of electrospinning, a co-axial needle was used to
incorporate live cells into the biocompatible polymer fiber during electrospinning [87]. A
highly concentrated cell suspension in media was pumped through the inner needle while a
high viscosity medical grade polydimethylsiloxane (PDMS) was fed through the outer
needle. By having a high dielectric medium (PDMS) in the outer needle and adjusting the
flow rates of both the solutions independently, the authors demonstrated the encapsulation
of more conductive cell aggregates within the PDMS fiber. Cell viability assay after 1
week of culture showed no difference in cell behavior compared to controls. In a more
recent study, the same group has developed a novel non-electric field driven technique to
fabricate threads for cell encapsulation applications. In this technique pressurized air is
directed through the centre of three-needle concentric nozzle while cell suspension and
driving polymer medium is ejected out through the outer two needles. A 3 week cell
survival assay performed with fluorescent activated cell sorting technique again proved no
detrimental effect of the process on cell viability [88].
Electrospinning has been very popular in the field of tissue engineering because it
is simple, economical and can generate porous scaffolds made of submicron diameter
fibers. In contrast to self assembly and phase separation discussed earlier that generated
fibers in true nanometer scale, the diameter of the electrospun fiber is on the upper range of
native ECM fibers (>500 µm). But this limitation is offset by the ability of this process to
produce a wide variety of scaffolds from both synthetic and natural polymers. In addition,
our understanding of the parameters that control the outcomes like fiber diameter and

26

morphology increase by the day and hopefully we should be able to manipulate these
variables intelligently to suit our needs.
The main challenge for electrospinning is to break into the nano-world in true
sense (<100 nm). The mechanical and physical properties of nano-world can be fully
realized only when fibers are in this range [89]. As an example, natural spider silk that is
synthesized as 20 nm fiber is the toughest material on earth today but electrospun silk
fibroin is nowhere close. It is the view of the authors that unless the electrospinning
technology evolves to generate <100 nm fibers the full potential of this process will not be
realized. Gu et al. evaluated the mechanical properties of a single electrospun fiber of
polyacrylonitrile by atomic force microscopy and found increased moduli with increasing
voltage. They hypothesized that higher voltage during electrospinning causes the jet to
accelerate faster resulting in greater elongation force and orientation of the polymer chains
in a fiber, contributing to increased modulus [90].
Keeping in pace with theoretical understanding of the process of electrospinning,
its application in tissue engineering has resulted in the development of scaffolds intended
for a wide variety of tissue-specific scaffolds. Excellent in depth reviews about the use of
electrospinning for tissue engineering applications are available [32, 91, 92] and this article
does not attempt to recapture the same detail. The most obvious advantage of
electrospinning as a fabrication strategy is the wide choice it offers in terms of polymer
(synthetic and natural) composition, concentration and in turn the fiber diameter, alignment
and density of the scaffolds.
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Synthetic materials offer the advantages of low cost, batch to batch consistency,
control over mechanical properties and degradation rates. A variety of synthetic polymers
including poly(lactic acid) (PLA), poly(glycolic acid) (PGA) [93],

poly(lactide-co-

glycolide) (PLGA) copolymers [94], polydioxanone (PDO) [95], polycaprolactone (PCL)
[82] and different blends of PLA-PCL [96] have been successfully electrospun to yield
scaffolds with diverse physical, mechanical and biological properties. The strength of
electrospinning lies in generating a plethora of scaffold types which in turn helps in
tailoring the scaffolds to suit different needs.
Scaffolds made from natural ECM proteins offer the advantage of increased
cytocompatibility and enhanced cell function. In an effort to make bio-mimetic tissue
replacements, there has been continued interest in using natural proteins for tissue
engineering applications. Various types of collagen and elastin are the primary structural
ECM proteins and efforts to electrospin these proteins have been successful. Matthews et
al. electrospun type I collagen, isolated and purified from bovine skin and demonstrated
preservation of characteristic 67 nm banding with TEM (Figure 4C). The fiber diameter
varied as a function of starting concentration and these scaffolds had to be cross-linked to
render mechanical stability [97]. Recently, however, Zeugolis et al. have shown that the
use of fluroalcohols used in electrospinning destroys the secondary structure of native
collagen [98] and thus leads to loss of all biologic function. However, our laboratory has
evaluated immune responses to electrospun gelatin and collagen following intramuscular
implantation in rats and found completely different host responses to these two
biomaterials. Collagen scaffolds became integrated to the tissues and showed complete
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infiltration but gelatin scaffolds showed chronic inflammatory response. It is the view of
the authors that these organic solvents might lead to partial denaturation of proteins or
simply place the collagen molecule in a thermodynamically stable conformation [99]. In
addition to type I collagen, types II and III, elastin, glycosaminoglycans, globular proteins,
fibrinogen have all been electrospun to form non-woven mats [32].
2.4. ELECTROSPUN BONE TISSUE ENGINEERING SCAFFOLDS
Materials that have been used in electrospinning bone scaffolds can be classified
into ceramics, synthetic or natural polymers used either alone or as a composite with
inorganic fillers.
2.4.1. Bioactive Glasses:

Bioactive glasses are an interesting class of ceramics that can form chemical bond
with the host bone at the interface. Such materials have been used in bone replacement
therapies predominantly in bulk form. In one study, precursor solution containing calcium
and phosphate in the molar ratio of 1.67 was mixed with a high molecular weight polymer
and electrospun. Subsequent heat treatment and calcination decomposed the polymer to
yield pure HA fibers [101]. Kim et al., electrospun sol-gel precursor solution mixed with
poly vinyl butyral to generate nano fibers of HA and fluoridated apatite (fHA). The fibers
were heated at the rate of 1oC/min to 700oC and held for 2 hours to remove any polymer
components and to induce crystallization of HA and fHA [102]. Subsequently, they
developed a novel composite by hybridizing heat treated electrospun bioactive glass
nanofiber with reconstituted type I collagen solution. The sol was processed differently and
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lyophilized to yield membranes or thick scaffolds. Incubation of these scaffolds on
simulated body fluid for 7 days resulted in formation of nanocrystalline carbonated apatites
that were chemically bonded to the scaffolds. Osteoblasts cultured on bioactive scaffolds
showed enhanced function (alkaline phosphatase assay) compared to those cultured on
collagen scaffolds [103].
Alumina and stabilized Zirconia has been used as bioinert ceramic for total hip
replacements because of its superior mechanical properties and excellent biocompatibility.
A recent study proved the possibility of electrospinning zirconia from an aqueous based
suspension of PEO:PEG and it would be interesting to observe if the results could be
exploited in tissue engineering [104].
2.4.2. Hydroxyapatite (HA) based scaffold systems:

Bone is a composite of organic collagenous matrix, inorganic hydroxyapatite (HA)/
carbonated apatite (CA) and non-collagenous proteins. Hydroxyapatite, being the normal
mineral of calcified tissues including bone, development of HA based scaffolds is being
intensely studied. The biological effects of HA including promoting osteoblast adhesion
and stem cell differentiation, is limited by its brittleness in bulk form. Polymer:HA
composites have been a huge effort designed to couple superior handling and mechanical
properties of polymers with biological activity of HA/CA.
2.4.3. ε-Polycaprolactone based systems:

Polycaprolactone has been popular for bone engineering scaffolds because of its
biocompatibility, slow degradation and the ease of electrospinning from a variety of
solvents. MSCs from rats cultured on electrospun PCL scaffolds supplemented with
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osteogenic media for 4 weeks showed complete penetration of the scaffolds with the
formation of multilayers, mineralization and collagen I were detected by von Kossa and
immunostaining respectively [105]. Incorporation of calcium carbonate and HA powders
to the polymer solution resulted in slight increase in the mechanical properties and fiber
diameters but did not affect the biocompatibility [106]. Another interesting application of
PCL:CaCO3 is guided bone regeneration membranes for periodontal surgery. A bi-layered
composite containing a carbonate rich functional layer and a PCL rich mechanical support
layer has been developed but has needs further characterization [107].
2.4.4. Chitosan based polymers:

Chitin is the second most abundant carbohydrate next to cellulose and its
deacetylated product is chitosan. Its derivatives have been long recognized for its
antifungal properties and its ability to induce protease inhibitors in plants [108]. One of the
earliest medical applications of chitosan was hemodialysis membranes [109] due to its
biocompatibility, high mechanical strength, film forming ability and non toxic degradation
products. Recently evidence point to role of chitin in the induction of fibroblasts and
angiogenesis [110] suggesting a role in immunity. Electrospinning chitosan:PEO blends
from acetic acid solutions has been successful [111, 112] and a preliminary investigation
into 90:10 PEO:chitosan blend showed that the scaffold is non-toxic and osteoblast
spreading in culture is optimal [113].
2.4.5. Silk fibroin based scaffolds:

Silk, a natural fiber extracted from cocoons of silk worms (Bombyx mori) has long
been used as sutures because of its excellent mechanical properties and biocompatibility.
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Functional 3D scaffolds generated by solvent casting-particulate leaching showed that
these are superior to collagen scaffolds in inducing bone-like tissue in vitro [114].
Electrospinning parameters for silk fibroin solutions blended with PEO was first reported
by Jin et al., for the generation of submicron sized fibers [115]. In a later study, silk
fibroin-PEO based blends were electrospun with or without BMP-2 and nano HA and
seeded with h-MSCs and cultured for 4 weeks. Significantly higher levels of calcium
deposition, DNA content and elevated levels of mRNA bone marker transcripts were
observed in silk-PEO scaffolds functionalized with BMP-2 and HA suggesting electrospun
silk-based scaffolds can be used as good delivery systems for cytokines and growth factors
[116].
2.4.6. Inorganic polymers: Polyphosphazenes

In contrast to organic polymers that have C-C bonds as the backbone,
phosphazenes are inorganic polymers that alternate double bonds between phosphorus and
nitrogen backbone. This inorganic backbone gives these compounds desirable properties
like optical, thermal and oxidative stability in addition to superior mechanical properties.
The versatility of this system is greatly increased by the customizing the organic functional
groups to the phosphorus atom of the backbone. Though phosphazenes for tissue
engineering applications was first introduced in early nineties [117], electrospinning
phosphazenes for bone scaffolds has been reported recently. Laurencin et al., successfully
electrospun a solution of polyphosphazene that was loaded 50-90% w/w with nanocrystalline hydroxyapatite and concluded that incorporation of nHA was maximal with a
theoretical loading of 50% [118].
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2.4.7 Starch based systems

Starch represents an abundant natural biomaterial that degrades into low molecular
weight chains of maltose and fructose and has been investigated for biomedical
applications including tissue engineering scaffolds. Blending corn starch (S) with organic
synthetic polymers-ethylene vinyl glycol (SEVA-C), ε-poly(caprolactone) (SPCL),
poly(lactic acid) (SPLA) and inorganic HA has resulted in a wide variety of biomaterials
for tissue engineering applications [119, 120]. Fiber bonding and melt based technologies
has been used to fabricate starch based matrices yielding micron sized fibers. Recently,
electrospinning was used to impregnate nanofibers into porous SPCL in an effort to
simulate the native ECM organization. Osteoblast-like cells and bone marrow stem cells
showed significant increase in viability and activity on combination scaffolds than on pure
fiber-bonded scaffolds [121].
2.5. CONCLUSION
It is now common knowledge that nano-scaled materials have properties that are
remarkably different compared to macroscopic systems. High strength, thermal and electric
conductivity, surface energy and reactivity are some of the features that make nanoengineering a modern revolution. The field of tissue engineering has been very quick to
adopt these principles of nanotechnology and has come a long way in a relatively short
span of time. Electrospinning along with self assembly and phase separation are tools that
are currently available that allow tissue engineers to explore the avenues of nanoworld.
Each of these techniques has something to offer that others fall short of. There is no doubt
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in the minds of the authors that continued research will increase the potency of existing
techniques and will introduce new ones in the coming decade. The recent explosion in the
number of publications and unified global efforts to view the macroscopic world from a
nano-scaled lens will act as a catalyst in exploiting these findings for best use in tissue
engineering and regenerative medicine.
Advances in preventive medicine (e.g. vaccines) and surgical care have
undoubtedly increased the mean life expectancy around the world. With increasing mean
patient age, the focus of future therapeutic approaches must now shift from ensuring
patient survival to improving the quality of life. Regenerative medicine and tissue
engineering are scientific disciplines that specifically arose to meet this challenge but
unfortunately advances in patient care are not being paralleled by corresponding
contributions from these fields. In spite of intense research for over a decade, the biggest
challenge in tissue engineering has been overcoming the barrier between bench work and
bedside. This said there is continued expectation from medical professionals and patients
alike and translating this promise to patients will be the priority in coming decades.
The techniques discussed in this review are expected to be refined and expand in
versatility. Experiments in self assembly of collagen triple helices already point to
important clues about the role of extracellular matrix on calcification in normal and
pathological states. These lessons from biology will be exploited in designing tissuespecific scaffolds. Phase separation process, though inexpensive, is limited by the number
of polymers that could be used. In addition, the specific parameters that would yield
fibrous morphology are yet not understood, even though scientific theories explaining the
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process exist. In the field of electrospinning, two obvious challenges are to break into the
nanoworld (<100 nm) and to address the issue of use of volatile organic solvents. Even
though self-assembly, phase separation and electrospinning can yield nanofibrous
structures, the operational window is pretty narrow and more importantly, the operator has
little or no control over the orientation and organization of these nanofibers into
macroscopic structures. Complementary research in nano-engineering, including nanoprinting, will provide new routes that offer more precise 3D control over the fabrication
process. One major thrust of future research would be to find avenues to make any or all of
these processes compatible for large scale-up without losing control over the higher spatial
organization of nanofibers. Rapid advances in stem cell biology and the use of in vivo
mimicking bioreactors for cell and organ culture, for instance, create unforeseen
possibilities to make living organ substitutes a reality within the next decade.
2.6. EXECUTIVE SUMMARY
The function of native ECM is intrinsically linked to its form.



Native ECM is an assembly of nano-scaled fibers that are at least an order of
magnitude smaller than the cells themselves.



Structural organization aside, it has domains that interact very closely with the cells
that reside in its vicinity.



Tissue engineering attempts to create tissue/organ-specific ECM analogues (scaffolds)
in terms of structure, dimensions and composition.
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Current fabrication strategies to generate nanofibrous scaffolds include
Self Assembly:



Biomimetic



Spontaneous organization of individual molecules into progressively higher-order
structures.



Scaffolds generated by this process are completely biocompatible (made from natural
biological molecules) and form true nanofibers (<100 nm).



Limitations include scaling-up and use of small peptide fragments.

Phase Separation:



Simple technique and does not require expensive equipments.



Easy to obtain batch to batch consistency.



Limitations include restricted choice of polymers and scale-up.

Electrospinning:



Easy, versatile, amenable to scale-up and currently most popular.



Criticisms include generation of fibers with diameters that are in the upper limit of
ECM.



Offers no precise control over the orientation and organization of fibers during
development of macro-scale structures.

36

Chapter 3: MULTIPLE FACTOR INTERACTIONS IN BIOMIMETIC
MINERALIZATION OF ELECTROSPUN SCAFFOLDS

Preface: The following section has been published in Biomaterials, October 2009, Vol.30,
Issue 29, 5456-5464.
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3.1. ABSTRACT
One of the major limitations in scaffold-based bone tissue engineering has been the
inability to increase the loading of biologically active inorganic mineral. The present study
introduces a novel two-step strategy to increase overall mineral content of electrospun
scaffolds and employs multiple factor interaction as a statistic to identify the combination
of factors that yields maximal scaffold mineralization. Different amounts of nHA (0, 10,
25 and 50% by wt. of polymer) were electrospun in combination with polydioxanone
(PDO) or poly(glycolide:lactide) to generate composite scaffolds. Successful incorporation
of nHA within, on and in between nanofibers was confirmed by transmission and scanning
electron microscopy. These scaffolds were immersed in different types (conventional,
revised, ionic and modified) of simulated body fluid (SBF), prepared at 1x and 4x
concentrations and the incubation was carried out either in static or dynamic setting at
biomimetic conditions. At 2 weeks, the total amount of mineral within the scaffold was
quantified using a modified alizarin red-based assay. Each of the five independent factors
was analyzed independently and tested for interaction using random effects ANOVA.
Statistics revealed significant higher order interactions among factors and the combination
of PDO containing 50% nHA incubated in 1x revised SBF resulted in maximum
mineralization.
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3.2. INTRODUCTION
Bone is a composite material composed of organic collagenous matrix and
inorganic nanocrystalline hydroxyapatite (nHA). The interaction between these phases
begins at the nanoscale when platelet-like HA crystals nucleate the gap regions of collagen
fibrils [122, 123] and elongate along the long axis of the fiber to form a mineralized
collagen fibril. Such an intimate association of dissimilar material phases is preserved
through hierarchical structure and gives bone its unique mechanical properties: high
strength, high fracture toughness and low stiffness [124, 125]. The ability of bones to
undergo cell mediated resorption and remodeling is critical in load bearing situations and
maintaining calcium homeostasis.
Structural bone substitutes made from ceramics, metals and polymers have been
popular in load-bearing bone and joint prostheses but problems of wear debris, corrosion,
stress-shielding and inadequate integration are still relevant. Efforts to achieve a strong
interface between a biomaterial and the host bone resulted in identifying a class of
ceramics called bio-glass. These compounds can form a chemical bond to the bone by
virtue of forming a calcium-apatite film on the surface [126, 127]. Since this discovery,
coating of bone implants with HA (or some form of ceramic) have been successfully
exploited to induce osseointegration at the interface [128-130]. However, since ceramic
coating (by plasma-spraying, sputtering or electrophoresis) requires the biomaterial to be
heat resistant or electrically conductive, success of this approach is restricted to metals
having simple shapes [131].
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In contrast to conventional methods of incorporating ceramic that involves high
temperature treatment, Abe et al. demonstrated new mineral deposition at low temperature
by immersion of a biomaterial in an aqueous solution of ions [131]. This method was
termed biomimetic because it involved incubation in simulated body fluid (whose ionic
concentrations are roughly equal to that of plasma) and mineralization occurred at
physiological temperature and pressure. Since such mineralization can occur on any
biomaterial, independent of shape, structure or composition and in a temperature range
consistent with the glass transition temperature of biocompatible synthetic polymers, we
adopted this strategy to increase the mineral content in synthetic polymeric scaffolds. In
addition, since low temperature precipitate of calcium phosphate is biologically active in
vivo, composite bone scaffolds containing this form of apatite would be more amenable for
bone tissue engineering.
Scaffold-based bone tissue engineering is a rapidly emerging field that focuses on
developing biologically-based substitutes that integrate with and are eventually replaced by
host bone [132]. It involves implantation of extracellular matrix (ECM) analogs that can
simultaneously support cell function and provide structural support. Incorporation of nHA
within the polymer matrix seems to be an attractive strategy in bone tissue engineering
because the dispersal of stiff and brittle HA crystals within the tough organic polymer
matrix would effectively inhibit crack propagation [133-135]. From a biological
perspective, presence of hydroxyapatite enhances protein adsorption, improves osteoblast
function [136, 137] and confer osteoconductivity [138] to scaffolds.
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In the present study, we sought to increase the loading of HA mineral within
electrospun scaffolds in two steps: 1) by directly incorporating nHA during electrospinning
and 2) by subjecting these composite scaffolds to incubation with simulated body fluid
(SBF). We hypothesized that in addition to directly contributing to overall mineral content,
seeded nHA during electrospinning will act as nucleation sites during SBF treatment for
further crystal growth. We tested this novel mineralization strategy on two synthetic
polymers (polydioxanone and poly (lactide:glycolide)) containing 0, 10, 25 and 50% (by
wt. of polymer) nHA. These scaffolds were then incubated in two concentrations (1x and
4x) of four types of simulated body fluids (conventional, revised, modified and ionic)
under either static or dynamic conditions. Finally, we took a statistical approach to analyze
the interactions effects of each of these variables to identify the best combination of factors
that would yield maximum in vitro scaffold mineralization.
3.3. MATERIALS AND METHODS
3.3.1. Characterization of Nanocrystalline Hydroxyapatite (nHA)
Commercially available nHA was purchased (Berkeley Advanced Biomaterials,
Inc. San Leandro, CA) and crystal structure was confirmed to be hydroxyapatite by
electron diffraction. The TEM evaluation shows a favorable elongated platelet-like
structure that had crystal size in the range of 30-100 nm, similar to that found in bone. The
results are presented in Figure 6.
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B

Figure 6: Initial characterization of commercially available nHA used in the study. (A) Transmission
electron micrograph showing platelet-like crystals having sizes ranging from 30-100 nm. (B) Electron
diffraction pattern confirming the crystal structure to be hydroxyapatite.

3.3.2. Composite Scaffold Preparation by Electrospinning:
Two different synthetic polymers - polydioxanone (PDO, Ethicon, Inc., NJ) and
85:15 poly(lactide-glycolide) (PLGA, Lakeshore Biomaterials, AL) were used for the
study. The final concentration of the polymers was adjusted to 100 mg per ml of
electrospinning solvent, 1, 1, 1, 3, 3, 3 hexafluoro-2-propanol (HFP) for all scaffold types.
Different amounts of nHA (0, 10, 25 and 50% by wt. to polymer) were dispersed in HFP
prior to addition of polymer and electrospinning. Since nHA crystals sedimented in HFP,
stable dispersion of nHA was achieved by sonicating the solution in pulse mode (on: 50
sec, off: 10 sec) at 38% maximum amplitude using a tapered tip of a Cole-Palmer
Ultrasonic Processor for 10 minutes. The stability of dispersion of nHA was confirmed
after 2 hours by visual inspection before adding pre-weighed amounts of PDO or PLGA.
Electrospinning conditions were optimized (rate: 7 ml/hour, air-gap distance: 20 cm,
voltage: 22kV) to generate continuous non-woven composite nanofibers that were
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collected onto a rotating rectangular mandrel (7.5 x 2.5 x 0.5 cm). After electrospinning,
scaffolds were removed from the mandrel, dried in the hood for 30 minutes and 10 mm
discs punched using a dermal biopsy punch. These discs were used for all mineralization
experiments.
3.3.3. Transmission and Scanning Electron Microscopy:
Fibers were collected directly onto copper grids during electrospinning and
analyzed using Jeol-JEM-1230 transmission electron microscope. For scanning electron
microscopy, air-dried electrospun scaffolds were mounted on aluminum stubs, sputter
coated with gold and examined at an accelerating voltage of 10kV using Zeiss EVO 50
XVP scanning electron microscope.
3.3.4. Biomimetic Mineralization with Simulated Body Fluid:
Four different types of simulated body fluids - conventional (c-SBF), revised (rSBF), ionic (i-SBF) and modified (m-SBF) were prepared following a published protocol
[139]. The ionic concentrations in these fluids vary with respect to chloride, bicarbonate
and calcium. Each type of SBF was prepared in two concentrations (1x and 4x) to study
the effect of increased ion concentration on scaffold mineralization. Electrospun scaffolds
were incubated in SBF under two conditions: static and dynamic. In static condition, the
discs were placed motionless in a tissue culture grade 24-well plate containing 3 ml of
corresponding SBF while dynamic incubation involved using a 55ml slow lateral turning
vessel (STLV) bioreactor (Synthecon, Inc., Houston, TX) rotating at 9 rpm. Both static and
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dynamic experiments were performed in an incubator at 37oC in 5% CO2 atmosphere for a
total of 14 days with SBF solutions renewed every 5 days.
3.3.5. Quantification of Mineralization using Alizarin Red S (ARS):
The mineralization of scaffolds was quantified using a modification of a published
protocol [140]. Alizarin Red S (Sigma, MO) was dissolved in deionized (DI) water to a
final concentration of 40 mM and pH was adjusted to 4.1 using 1M NaOH. The solution
was then filtered through a 0.8 µm mesh to remove any particulates and stored in the dark.
After two week incubation, scaffolds were rinsed thrice for 10 minutes each in DI water,
transferred into a new 24-well plate and fixed in 3.7% buffered formaldehyde for 30
minutes. The scaffolds were stained with an excess of Alizarin Red S (ARS) solution for
20 minutes on an orbital shaker, following which the scaffolds were rinsed repeatedly in
DI water till all unbound dye was washed off (as evidenced by appearance of a clear wash
solution). At this time, the scaffolds were transferred to a new plate and the bound dye
solubilized with 50% acetic acid solution. After 30 minutes, the solubilized stain was
pipetted out, diluted 1:4 in water, pH adjusted to 4.1 and the absorbance at 550 nm
measured in a 96-well plate using SpectraMax Spectrophotometer (Molecular Devices).
3.3.6. Bovine Serum Albumin (BSA) Experiments:
Since plasma is necessary and sufficient to induce mineralization in vivo, we
evaluated the ability of rSBF (whose ionic composition matches that of plasma) in the
presence of albumin – the most abundant serum protein, at 40 g/L concentration [141]. An
experiment was designed in which PDO and PLGA scaffolds containing different amounts
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of nHA (0, 10, 25 and 50% by wt. of polymer) were incubated with 4x r-SBF with and
without 4% BSA under static conditions at 37oC in 5% CO2 atmosphere. Freshly prepared
solution was replenished every 5 days and ARS staining and quantification were done as
described above.
3.7. Statistical Analysis:
The five-factor (2 scaffold types x 4 concentrations of nHA x 4 types of SBF x 2
concentrations of SBF x 2 incubation conditions) study (with n=3) yielded a total of 384
scaffolds. The resulting data was analyzed using random effects ANOVA. The outcome of
interest was the mineralization after 2-week incubation as measured by alizarin red
quantification.

The ANOVA model included all the main effects and all possible

interaction effects (2, 3, 4, 5 factor interactions). The statistical significance level was set at
5% level. Diagnostics were performed to verify the model assumptions (of normality and
homoscadasticity) and to detect outliers. When warranted, transformation of the outcome
was considered. The analyses were performed using Minitab 15® (Minitab Inc. PA) and
JMP-7® (SAS, NC) software.
One-way ANOVA was performed and results analyzed for significance (α=0.05) to test
effects of BSA on mineralization.
3.4. RESULTS
3.4.1. Electron Microscopy:
The transmission electron micrograph provides evidence for the presence of
inorganic mineral within the fiber. Pure polymer fiber when examined by TEM is
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characterized by a lack of contrast and homogeneous density (Figure 7A), whereas a
composite fiber containing both nHA and polymer exhibits a stark contrast between
electron-dense inorganic crystals against the pale polymer background. Since the diameter
of the representative composite fiber in Figure 7B is around 150 nm, yet the longest
dimension of the nanocrystals is around 100 nm, we observe a definite trend for elongated
crystals to be aligned along the length of the polymer fiber. The SEM shows individual
fibers that are not uniform and also discrete clustered aggregates in between fibers. This
suggests the presence of hydroxyapatite within, on and in between the surface of fibers
(Figure 7C). Hence, the strategy of electrospinning nHA along with the polymer results in
oriented incorporation of crystals within the individual fibers as well as random
distribution throughout the 3D scaffold.
A

B

C

500 nm

Figure 7: A and B. Transmission electron micrographs confirming successful incorporation of nHA
within the electrospun PLGA polymer (A) and PLGA-nHA composite scaffolds (B). Note the uniform
density of pure polymeric fiber in A. In contrast, fibers containing nHA show a high contrast due to the
presence of dense inorganic nHA crystals within the polymeric fiber (scale bar = 100nm). C Scanning
electron micrograph of the composite scaffold showing irregular particulates on and between individual
fibers (scale bar = 5µm).

Scaffolds incubated in different SBFs were analyzed for mineral deposits after 2
weeks by SEM. All scaffolds exhibited mineral deposition to some degree. Whereas some
scaffolds showed significant deposits, others had a limited mineralization. Figure 8 shows
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representative PDO and PLGA scaffolds incubated in revised and ionic SBFs that
represent the conditions of maximum and minimum mineralization (as confirmed by
quantification with alizarin red staining). It can be observed that PLGA scaffolds under
both conditions exhibit a surface or layered deposition whereas PDO scaffolds demonstrate
mineralization of individual fibers. This observation could partially account for the
difference in actual amount of mineral deposited in these two synthetic polymeric
scaffolds.
0% nHA
i-SBF

50% nHA
i-SBF

0% nHA
r-SBF

50% nHA
r-SBF

A

B

C

D

E

F

G

H

PLGA

PDO

Figure 8: Scanning electron micrographs of electrospun PLGA (top) and PDO (bottom) scaffolds
containing 0% and 50% of nHA incubated in i-SBF and r-SBF for 2 weeks. These conditions
represent respectively the combination of factors that resulted in minimal (A) and maximal (H)
scaffold mineralization as determined by ARS. PLGA scaffolds show a dense aggregation of mineral
restricted to the surface. This is most evident in D where even though surface fibers and pores are
obliterated by mineral deposition, individual fibers away from the surface do not show signs of
mineralization. In contrast, PDO scaffolds exhibit retention of fiber structure and pores on the surface.
Yet, mineralization of individual fibers results in greater overall mineral content.

3.4.2. Alizarin Red S (ARS) Staining Quantification- Initial Validation:
Our first efforts were directed to optimize the ARS staining and quantification of
hydroxyapatite present in electrospun 3D scaffolds. We electrospun different amounts of
nHA (0, 10, 25 and 50 % by wt. of polymer) dispersed in solution of PLGA and PDO to
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generate a variety of composite scaffolds. These scaffolds were directly stained with ARS
(without subjecting to SBF treatment) to investigate if the staining and quantification
protocol is sensitive enough to detect the mineral incorporated during electrospinning. The
results shown in Figure 9 indicate that staining intensity of ARS (measured by
absorbance) increased linearly (R2=0.9477) as a function of amount of nHA added to
polymer solution. These data validates the ARS to detect and quantify the amount of
mineral present in a 3D scaffold.
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Figure 9: Plot of absorbance (at 550 nm) as a function of amount of pure nHA. A. 1:2 serial dilution of
nHA dispersed in water was used to quantify the absolute amount of nHA using the alizarin red staining
described in the methods section. B. PDO was added to a dispersed solution of nHA containing different
amounts of nHA and electrospun to generate composite scaffolds. Quantification with Alizarin red shows
a good correlation between increasing amounts of nHA and absorbance. This data validates alizarin red
staining assay to quantify the amount of mineral even in 3D electrospun scaffolds.

3.4.3. Multiple Factor Interaction:
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In the present study, we stained the mineralized scaffolds with Alizarin red S,
solubilized the stain in acetic acid and measured the absorbance of this solution at 550 nm
(peak absorbance of alizarin red). Hence, absorbance at 550 nm indirectly represents the
amount of mineral present within the scaffolds and is the only dependent variable. Since
the distribution of residuals revealed non-linearity, logarithmic transformation of actual
absorbance values was performed and was used as an indicator of outcome for quantitative
purposes. The five independent factors (with corresponding levels in parentheses)
represented alphabetically from A-E are: A. scaffold type (PDO, PLGA), B. concentration
of nHA (0, 10, 25 and 50 % by wt), C. type of SBF (c-, r-, i-, m- SBF), D. concentration of
SBF (1x and 4x) and E. incubation conditions (static and dynamic).
If the experimental design involves study of more than one independent variable
(factor), there is always an interaction within the factors that affects the outcome, whether
significant or not. Interaction effect analyzes the effect of one factor on the outcome at
various levels of another factor. In contrast, main effects analyze the influence of a factor
averaging over the levels of another factor. The presence of significant interaction implies
that the main effects are not additive, suggesting potential synergy or antagonism between
them. This makes the interpretation (of multiple factor experiment) solely based on main
effects at best incomplete or at worst misleading. Hence, the rule of thumb in statistics is to
interpret significant highest factor interactions first before examining the lower factor
interactions or main effects. As an inference, higher order significant interactions represent
the most complete explanation of the observed effects. The interaction effects in the
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present study were analyzed with ANOVA to detect, estimate and quantify the strength of
interaction among different factors.
The ANOVA results regarding the significance of the 5 main effects, ten 2-way,
nine 3-way, five 4-way and one 5-way interaction on the outcome are presented in Table
1. Significance was observed on all main effects and 2-way interactions. All 3-way
interactions except two and all 4-way interactions with the exception of one were
significant. In the present study, the highest factor interactions that were significant
involved four factors. Of the four 4-factor interactions possible: ABCD, ABCE, ABDE and
BCDE, only ABDE was not significant at α=0.05. All these are presented in a graphical
format in the Figure 10. Log (abs 550 nm), a direct measure of mineralization, is the
outcome plotted along the Y-axis in all the graphs. We explain one such interaction
(ABCD) in detail, while reminding the readers that others are interpreted in the same way.
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TABLE 1: A table of significance of 5 factor interaction on mineralization (absorbance). All levels
of interactions are statistically significant with the exception of three indicated by # (p<0.05).
General Linear Model: Log (Abs at 550nm) versus Factors A, B, C, D, E (defined below)
Factor
A (Scaffold type)
B (Concentration of nHA)
C (Type of SBF)
D (Concentration of SBF)
E (Incubation condition)

Levels
2
4
4
2
2

Values
PDO, PLGA
0, 10, 25, 50
c-SBF, i-SBF, m-SBF, r-SBF
1X, 4X
Dynamic, Static

Analysis of Variance for F, using Adjusted SS (sum of squares) for Tests
Source

A
B
C
D
E
A*B
A*C
A*D
A*E
B*C
B*D
B*E
C*D
C*E
D*E
A*B*C
A*B*D
A*B*E
A*C*D
A*C*E
A*D*E
B*C*D
B*C*E
B*D*E
C*D*E
A*B*C*D
A*B*C*E
A*B*D*E
B*C*D*E
Error
Total

DF

Sequential
Sum of
squares
(Seq.SS)

Adjusted
Sum of
squares
(Adj. SS)

Adjusted
mean
squares
(Adj. MS)

F

P

1
3
3
1
1
3
3
1
1
9
3
3
3
3
1
9
3
3
3
3
1
9
9
3
3

35.06241
14.94664
8.00487
1.44741
0.36104
2.76068
2.03314
2.92773
0.00530
0.98436
0.45471
0.61600
5.65736
1.25085
0.45216
0.60151
2.51492
0.40203
1.50544
0.50891
0.08604
0.72171
1.31584
0.04798
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0.14731
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1590.45
263.33
170.44
143.00
54.78
46.27
49.15
93.86
11.25
4.88
10.46
13.26
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25.31
14.15
3.46
43.66
9.13
31.22
11.67
6.61
5.43
10.06
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1.61

0.000
0.000
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0.000
0.000
0.000
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0.000
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0.011
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0.452 #
0.188 #

9
9
3
9
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371

0.64875
0.92130
0.01364
0.76570
3.74902
90.83806

0.66051
0.84690
0.00832
0.76570
3.74902

0.07339
0.09410
0.00277
0.08508
0.01464

5.01
6.43
0.19
5.81

0.000
0.000
0.904 #
0.000
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Figure 10: Four factor interaction graphs of biomimetic mineralization of electrospun scaffolds. In
multiple factor interaction study, interpretation of highest factor interactions (4 factors here) that are
significant accounts for the observed effects. The Y-axis log (absorbance at 550 nm), reflects
mineralization. Different concentrations of nHA incorporated are represented as: 0% (filled diamonds),
10% (open circles), 25% (filled triangles) and 50% (open squares). Different types of SBF (c, i, m and r)
are labeled along X-axis. The interaction effects observed are quantitative changes in the amount of
mineralization. While three interactions are significant, A*B*D*E is non-significant. Note similar trends,
superior performance of PDO, greatest mineralization with 50% nHA and r-SBF. While 1x is better than
4x in all kinds of SBF, static or dynamic incubation conditions do not significantly affect the outcome.

The most obvious finding from the graphs of ABCD interaction is that the
interaction effects are quantitative, rather than qualitative, in nature. This means the effect
of one factor merely increases or decreases the outcome at different levels of another factor
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without reversing trends or directions. More specifically, the following inferences emerge
from the figure.
First, PDO is always superior to PLGA (in some cases by almost a factor) in its
ability to mineralize under biomimetic conditions. This finding is significant, given the
popularity of PLGA in bone tissue engineering. Since the tendency to mineralize increases
with greater amounts of nHA added during electrospinning, our results indicate that
simultaneous electrospinning of PDO and nHA is a successful strategy in bone tissue
engineering. Current experiments in the lab are underway to exploit the two-step
mineralization process to improve mechanical properties of bone engineering scaffolds.
Second, incorporation of nHA (B) during electrospinning significantly increases
overall mineralization irrespective of scaffold type (A), type of SBF (C) or its
concentration (D). Further, increasing amounts of nHA resulted in progressively greater
mineralization, with 50% nHA containing scaffolds yielding the best outcome. This
general trend supports our rationale that addition of nHA during electrospinning favors
biomimetic mineralization by providing nucleation sites for mineral deposition.
With respect to different types of SBFs for their ability to mineralize electrospun
polymeric scaffolds, i- and m-SBF are generally inferior to c- and r-SBF whether at 1x or
4x concentration. The superior performance of r-SBF is also independent of whether PDO
or PLGA is used. This would mean that increased ionic density as a strategy to improve
mineralization, i.e. use of 4x instead of 1x, is not necessarily advantageous and the use of
1x r-SBF is at least as good as a higher concentration.

53

To sum up, the combination of PDO containing 50% nHA incubated in 1x r-SBF
for 2 weeks gives the maximum scaffold mineralization and with this specific set of
parameters, it does not matter whether the incubation is done under static or dynamic
conditions.
A full 2-way interaction plot matrix (containing all 10 interactions) is presented in
Figure 11 to give preliminary insight into the process and to verify the findings. The five
independent factors are listed along the diagonal. The plot is symmetrical (mirror image)
about this diagonal and hence it is typically sufficient to look at either one of the
corresponding panels. Graphically, an interaction is identified by comparing the slopes of
the lines: if the lines are parallel, there is no interaction; the greater the lines depart from
being parallel, greater the degree of interaction. It can be inferred from the graph that there
are significant interactions between different factors. One of the powerful attributes of
interaction studies is that it enables one to identify the exact combination of factors that
would represent the most favorable outcome. The set of parameters that yielded maximum
mineralization of electrospun scaffolds are: PDO pre-seeded with 50% (by wt.) of nHA,
incubated in 1x r-SBF under static conditions.
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Figure 11: Two-factor interaction plot matrix demonstrating the presence and strength of
interactions on mineralization, represented by log (absorbance at 550 nm). The five independent
variables are listed along the diagonal and the ten possible two-factor interactions are plotted at the
intersection of the corresponding factors. Interaction is present if the slopes of the lines are not
parallel and greater this deviation from parallel, greater is the strength of interaction.

3.4.4. BSA Experiments:
The results of mineralization experiments in the presence and absence of BSA is
presented in Figure 12. First, the previous finding with respect to the superior performance
of PDO compared to PLGA was confirmed. Similarly, incorporation of nHA as part of
scaffold fabrication during electrospinning is a successful strategy to increase the amount
of mineral loaded in the electrospun scaffold. This confirms the rationale for a two step
mineralization process. Further, the presence of BSA in the SBF always has a negative
impact on the mineralization process. However the inhibitory effect of BSA is more
pronounced on PDO scaffolds compared to PLGA scaffolds.
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Figure 12: Effect of serum albumin on mineralization of PDO and PLGA scaffolds upon treatment with
4x r-SBF for 2 weeks. The data supports previous observations that mineralization of PDO is superior to
PLGA scaffolds and increasing amounts of pre-seeded nHA results in greater mineralization.
Interestingly, the inhibitory effect of BSA is more potent in nHA containing PDO scaffolds compared to
PLGA scaffolds. This effect might be the result of adsorption of BSA onto nHA and subsequent masking
of the critical nucleation sites.

3.5. DISCUSSION:
Calcium phosphates (CaP) have been used as a synthetic bone substitute for almost
a century because they are the main constituents of bones and teeth. The family of CaP
encompasses multiple compounds including but not restricted to dicalcium phosphate
dihydrate, octacalcium phosphate, hydroxyapatite (HA), tricalcium phosphate (TCP),
amorphous calcium phosphate (ACP) and carbonated apatite (CAP). These compounds
vary mainly in the Ca:P ratio and the form commonly found in bone is carbonated apatite,
otherwise referred to as bone apatite. Amorphous calcium phosphates are not normally
found in mature hard tissues yet they are an important intermediate in the transition to
more stable crystalline forms including hydroxyapatite [142]. Bohner [143] distinguishes
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two types of CaP based on the temperature of synthesis: a high temperature sintered form
(> 900oC) and a low temperature precipitate (~37oC). The compounds synthesized at low
temperature exhibits more solubility, much greater surface area and are inherently more
active in biological systems in contrast to biologically inert sintered versions. Solubility of
low temperature precipitated HA which is a function of crystal size and foreign ion
substitution, is closer to that of fast resorbing tricalcium phosphate. For example, carbonate
ion substitution of HA results in the formation of highly soluble carbonated apatite.
Sintered HA most commonly used in load-bearing orthopedic implants, on the other hand
is not bio-resorbable as they are stable over a lifetime of the individual.
In this regard, it is important to realize that the bone mineral (biological apatite)
are non-stoichiometric with different types and foreign ion substitution including sodium,
magnesium, potassium, carbonate and fluoride. These substitutions make biological
apatites different from stoichiometric hydroxyapatite which has only calcium and
phosphate. Ion substitutions affect crystal morphology, decreases crystallinity and
increases solubility [144]. This finding is of special relevance because the foundation of
tissue engineering rests on the ability of a product to be remodeled and resorbed with time.
Plasma or the extracellular fluid is the source of the ions responsible for
physiological and pathological mineralization in vivo. Kokubo and others [131, 145]
developed a biologically relevant strategy of inducing new mineral formation using
simulated body fluid (SBF) whose ion concentrations, pH and temperature are similar to
that of human plasma. More importantly, they successfully demonstrated deposition of
bone-like apatite on all major classes of biomaterials (ceramics, organic polymers and
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metals) when incubated with SBF. Since this mineralization process occurred at
biologically relevant pH (7.4) and temperature (37oC), this was called biomimetic
mineralization. The final apatite formed, in spite of having variable composition, is
predominantly carbonated apatite with low crystallinity and is very similar to the form
found in bone, a favorable factor from a tissue engineering perspective [146].
Recently, it has been shown that electrospun poly(l-lactic acid) (PLLA) scaffolds
can be used as a substrate for hydroxyapatite mineralization.

Chen et al. incubated

electrospun PLLA scaffolds in SBF and performed an extensive characterization of the
mineral deposited on the nanofiber surface over 4 weeks. They found that while the
amount of mineral increased with time, its composition did not change. The predominant
mineral deposited by biomimetic mineralization procedure was carbonated apatite [147].
While this work used SBF treatment to mineralize electrospun scaffolds, it differs
significantly from the present study: incorporation of a significant amount of nHA during
electrospinning (as much as 50% by wt. of polymer) which also primes these electrospun
composite scaffolds for better mineralization by providing nucleation sites.
It was identified that the two factors critical to apatite mineralization are the
availability of favorable nucleation sites coupled with localized super-saturation of calcium
ions [148]. Spontaneous mineralization is seldom observed in meta-stable solutions of
plasma or SBF in spite of them being supersaturated with respect to calcium and phosphate
ions. This is because of presence of a high energy barrier for the nucleation event to occur.
Since apatite mineralization follows the principles of heterogeneous nucleation, the
presence, number and potency of nucleation sites are rate-limiting factors [149]. These
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specialized areas of the substrate reduce the energy barrier sufficiently to allow nucleation
to occur. Once stable nuclei have formed, subsequent crystal growth in solution is
thermodynamically driven as long as concentration gradient for the ions exists.
Several approaches have been undertaken to exploit these observations to induce
biomimetic mineralization onto substrates. One method is to functionalize the biomaterial
surface with reactive groups like Si-OH [150], Ti-OH [151], COO- [152], that would
provide nucleation sites for apatite formation. In this regard, some functional groups might
be more potent than others in their ability to nucleate apatite crystals. An alternate
approach aims at satisfying the second criteria for nucleation to occur: increasing the local
concentration of calcium ions. This has been successful by pre-treatment of substrates with
CaCl2 or Ca (OH)2 or by increasing the ionic activity product (using higher concentrations
of SBF).
Our objective was to integrate both these requirements for mineralization based on
the rationale that pre-seeded nHA crystals can act as stable nucleation sites for rapid crystal
growth when incubated with SBF in addition to being a local reservoir of calcium ions.
Such a strategy would preclude the dependence of mineralization on high energy and
dynamic nucleation events by providing stable apatite nuclei. We devised a two-step
mineralization process: incorporating nHA crystals within the nanofibrous scaffold during
electrospinning (internal mineralization) followed by incubation in SBF (external
mineralization) for 2 weeks. The total mineral content at the end of the experiment would
be the sum of pre-seeded nHA, crystal growth on pre-seeded nHA as well as de novo
mineralization of electrospun fiber.
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Alizarin Red S is an anthraquinone derivative that forms a water-insoluble salt with
calcium. It is a simple, sensitive and inexpensive method and has been routinely used as a
qualitative assay for confirming the presence of calcium deposits. Even though the stain
binds to calcium mineral in a quantitative manner, the inability to be accurate quantify the
bound stain has been its major limitation. Recently, it has been shown that the stain can be
solubilized and absorbance measured at 550 nm to quantify the mineral content in 2D
culture plates [140]. Our study has successfully adapted this technique to study mineral
content in porous 3D tissue engineering electrospun scaffolds. One caveat of using ARS to
quantify mineral is that the stain cannot distinguish between different types of calcium
phosphate crystals and hence further investigation and confirmation of these individual
crystal types by X-ray photoelectron spectroscopy or X-ray diffraction techniques is
needed.
Since internal mineralization was designed to incorporate nHA within the
polymeric scaffold during electrospinning, initial characterization of commercially
available nHA with respect to crystal morphology and size was performed. TEM showed
elongated platelet-like morphology of these crystals with size ranging from 30-100 nm,
similar to that observed in bone. Since typical electrospun fibers have a diameter in the
range of 500-1000 nm, we reasoned that these crystals can be successfully incorporated
within the fiber, if electrospinning conditions were optimized.
Efficient dispersal of nHA with the dissolved polymer solution is imperative for
successful electrospinning of nHA-polymer composite scaffold. Commercially available
nHA formed dense aggregates that sedimented out of solution when added to
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electrospinning solvent (HFP). Effective dispersal of nHA in HFP was accomplished by
sonication for 10 minutes in pulse mode to prevent overheating and evaporation of solvent.
The stability of dispersion was confirmed by visual appearance of a homogeneous milky
white appearance of the solution after 2 hours before appropriate amount of polymer was
added. Electrospinning parameters were then optimized to generate continuous nanofibers.
This sequence of dispersing nHA in the solvent prior to addition of polymer was done to
prevent any inadvertent polymer breakdown during sonication.
External mineralization of scaffolds was accomplished by incubation with cell- and
protein-free SBF that was designed to mimic plasma with respect to ionic concentrations,
pH and temperature. The concentration of chloride and bicarbonate ions in the first
prototype of SBF (conventional or c-SBF) differs from that of plasma sufficiently that it
can induce apatite formation that is different from that of native bone-apatite.
Subsequently, efforts were taken to produce SBFs whose inorganic ions concentration
would more closely mimic plasma. These experiments resulted in generation of revised (rSBF), ionic (i-SBF) and modified (m-SBF) versions of simulated body fluids. The r-SBF
was designed to match plasma concentrations of every ion, while i-SBF have concentration
of dissociated ions equal to that of plasma and m-SBF is similar to r-SBF except that the
concentration of bicarbonate ions is decreased to the level of saturation with respect to
calcium carbonate. We included these different compositions of SBFs in our study because
each SBF represents one aspect of human plasma and the significance of one or the other
in their ability to mineralize electrospun scaffolds has not yet been studied. Even though
Oyane et al. [139] concluded that m-SBF was optimal for biomimetic mineralization, we
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found that r-SBF gave the maximum mineralization under all conditions, while i- and mbehaved identical and were generally inferior. This apparent contradiction can be
accounted for by the difference in our experimental design. The loss of biological activity
reported was not observed in any of the SBFs until 2 weeks but became significant only in
r- and i-SBFs over a period of 8 weeks. Since we replenished scaffolds with fresh SBF
every 5 days, the loss of bioactivity was irrelevant and the changes observed indicate
difference in intrinsic mineralization potential of various types of SBF. In addition to
varying the types of SBF, the ionic product (IP) of SBFs were studied by repeating
experiments with a higher concentration (4x versus. 1x). The results show a predictable
increase in mineralization with increasing IP in PDO while PLGA scaffolds showed an
opposite effect.
The most striking observation in our experiments has been the behavior of PDO
vis-à-vis PLGA with respect to mineralization potential. The superior performance of PDO
compared to PLGA can be attributed to the fact that PLGA scaffolds exhibited significant
dimensional change (shrunk almost by 60% of its original size) while PDO retained its
original form (Figure 13). This change is accompanied by a more dense aggregation of
fibers and a dramatic decrease in available surface area. Such a structural change in the
PLGA scaffold seems to induce overall surface mineralization of the scaffold rather than
mineralization of individual fibers as confirmed by electron microscopy. In contrast,
individual fibers can still be seen in PDO scaffolds at the end of incubation and mineral
deposits are evident on these fibers.
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Figure 13: Effect of incubation conditions on mineralization of electrospun scaffolds
containing 0% and 50% by wt. of nHA. All the scaffolds shown were incubated in 1x r-SBF for
15 days and stained with alizarin red to visually follow the mineralization. A represents
incubation at 25oC in a closed environment, B incubation at 37oC in a closed environment and
o
C incubation at 37 C open to 5% CO2 atmosphere. It can be readily seen that the PLGA
scaffolds exhibit a dramatic dimensional change at 37oC but not at room temperature. PDO
scaffolds maintain their form irrespective of the temperature. The intensity of staining seen in
nHA containing scaffolds (bottom row) represents both seeded nHA as well as new mineral
deposited during SBF treatment. The defects observed in the scaffolds represent areas
punched out for SEM evaluation prior to staining.

The cumulative mineral deposition from all the individual fibers seems to account
for the significantly superior performance of PDO compared to PLGA scaffolds.
Interestingly, the shrinkage in PLGA scaffolds is observed only under incubation at 37oC
and not at room temperature. This change occured independently of exposure to CO2.
Another possible reason for inferior mineralization of PLGA scaffolds may lie in the
chemistry of the polymer. The PLGA scaffolds used in the present study is ester-capped to
delay degradation. The end capping of the polymer with lactic acid ethyl ester prevents
formation of free terminal carboxyl groups which might otherwise initiate nucleation of
calcium phosphate mineral and increase mineralization.
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3.6. CONCLUSION:
A reliable quantitative assay for mineralization that occurs within porous 3D
nanofibrous scaffolds has been successfully developed. Our strategy of incorporating
mineral in two steps-first during electrospinning and later by incubation in simulated body
fluids at physiological relevant temperature, pH and pressure is shown to be capable of
inducing new mineral deposits on synthetic biocompatible polymers. Multiple-factor
interaction statistics revealed some interesting insights into the mineralization behavior of
electrospun polymeric scaffolds that led to identifying the best combination of factors that
result in maximum mineralization. The amount of mineral deposited varies directly as a
function of concentration of inorganic nHA seeded during electrospinning. This confirms
our hypothesis that the nHA seeded act as nucleation sites for further crystal growth upon
treatment with SBF. This nHA can act as a reservoir for calcium and phosphate providing
localized super-saturation of these ions further facilitating new crystals to be formed. In
addition, the two synthetic polymers tested-PDO and PLGA are markedly different in their
ability to mineralize with PDO being superior. The r-SBF was the most efficient SBF in
inducing mineralization of all types of substrates.
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Chapter 4: MULTI-LAYERED ELECTROSPUN SCAFFOLDS - A
NEW APPROACH

4.1. INTRODUCTION
Bone tissue engineering faces a twin challenge of satisfying mechanical and
biological properties. Since bones play a vital role in bearing load and protecting internal
organs, synthetic bone substitutes are subjected to considerable stresses following
implantation. In this instance it is important to realize that precise matching of the physical
properties of bone with synthetic substitutes is essential. It is becoming increasingly clear
that materials that are stiffer than bone itself (metals, ceramics and plastics) contribute to a
phenomenon called stress shielding. In this process, there is ineffective transfer of stresses
between the high stiffness implant and the healthy bone, resulting in resorption of normal
bone around the implant. Ultimately, secondary bone fractures occur and the implant fails.
These occurrences further underline the importance of matching bone with the implant in
terms of mechanical properties. In addition, such inert implants are not susceptible to
physiological bone remodeling that might be induced by changing load patterns,
parathyroid hormone and calcium homeostasis. It is the endeavor of tissue engineering to
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address these vastly diverse requirements by providing a temporary scaffold that is
mechanically strong enough to endure loads during the healing phase before being replaced
by healthy host bone formed de novo.
One of the reasons metals, ceramics and polymers perform better under loading
conditions is because these dense, non-porous materials have excellent bulk material
properties. However, being biologically inert and not able to induce a specific cellular
interaction is a serious limitation. Electrospun materials are inherently advantageous in this
context because they are biocompatible and provide nanofibrillar topography for cells to
attach, migrate and proliferate. Even though electrospinning offers great promise in
generating biologically optimal scaffold with respect to its geometry, dimensions and to
some extent composition, the fact that these scaffolds are more than 90% porous greatly
facilitates the above process. However, porous materials have very poor mechanical
properties. Efforts to improve the physical properties of electrospun scaffolds without
compromising the advantages that the process renders are a pertinent area of research.
Bone is a structural composite with brittle, inorganic hydroxyapatite filler particles
closely associated with a tough organic collagenous matrix. A strong bond between these
two distinct phases ensures effective transfer of stresses, renders the material bone with
excellent mechanical properties and also is critical for biological function. Given the role
of hydroxyapatite in determining mechanical and biological properties, we sought to
exploit findings of the previous study demonstrating successful incorporation of biological
apatite onto electrospun scaffolds. In addition, we introduce pressure-welding as a novel
strategy to improve the mechanical properties of electrospun scaffolds.
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4.2. MATERIALS AND METHODS
4.2.1. Scaffold Preparation by Electrospinning:
PDO and PDO:nHA composite scaffolds were fabricated by electrospinning
following the methods described earlier. Only the 50% nHA (by wt of PDO) was chosen
for this study as it was shown to have maximum mineralization potential. Since PLGA was
inferior to PDO it was not considered. In addition, control PDO scaffolds with no nHA
incorporated were electrospun.
4.2.2. Scanning Electron Microscopy, SBF Treatment and Alizarin Red Staining:
Methods described in the previous section were followed. PDO and 50%
PDO:nHA scaffolds were incubated in 1x r-SBF for 2 weeks under biomimetic conditions.
Control scaffolds were incubated under similar conditions in DI water.
4.2.3. Pressure Welding:
Electrospun scaffolds were subjected to mineralization and compression in two
different sequences: one set of electrospun scaffolds were compressed before mineralizing
treatment with SBF (C1M2) while in the other group mineralization was performed first
before compressing multiple layers (M1C2). The number of layers stacked during
compression was either1, 2 or 4. All scaffolds were cut into flat rectangular sheets
carefully avoiding any edges. These scaffolds were placed flush on top of each other on
flat stainless steel blocks. These blocks were then placed in a mechanical hydraulic press
(Carver Instruments) and subjected to 20,000 psi and the pressure held constant for a
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period of one minute. After this the scaffolds were removed and either tested for
mechanical properties or stored for SBF treatment. For multi-layered scaffolds that were
mineralized first followed by compression (C2M1), a virgin PDO sheet was placed in
between two mineralized scaffold to act as a plasticizer i.e. flow under pressure and bond
adjacent layers and prevent delamination.
4.2.4. Mechanical Testing:
The scaffolds were punched into dog-bones with a metal punch (2.75 mm wide at
their narrowest point, gage length of 7.5mm) and individual specimen thickness was
measured on a Mitutoyo IP54 digital micrometer (Mitutoyo American Corp.). These dogbones were subjected to uniaxial tensile testing using a 50 N load cell MTS Bionix 200
testing system with an extension rate of 10 mm/min. Elastic modulus, strain to failure and
energy to break were recorded by the MTS software TestWorks 4.0.
4.2.4. Permeability and Pore Size Measurements:
Both types of scaffolds - C1M2 and M1C2 containing 1, 2 or 4 layers were
subjected to permeability and pore size measurements following the protocol developed by
Sell et al. [153]. Briefly, a graduated 10-mL pipette was placed horizontally that was
connected to a reservoir at a height of 150 cm from the scaffold. The electrospun scaffold
was compressed between two silicone gaskets and a large-pore metal screen was placed on
the underside of the scaffold to prevent excessive distension of the test scaffold. Fluid flow
was recorded every minute for the first 10 min of testing and the permeability was
mathematically calculated using Darcy’s equation. These permeability values were then
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used to determine the average pore sizes of the electrospun scaffold, again using a
mathematical equation.
4.3. RESULTS
4.3.1. Scanning Electron Microscopy:
One of the surprising findings from scanning electron micrographs is the
preservation of porous structure of nanofibrous scaffolds even after compression. The
nanofibrous architecture appear more dense but without obliteration of pores, at least on
the surface. This is true even of multilayered scaffolds that were compressed before or
after mineralization. There are discrete patches on the scaffolds where the fibers have
deformed and flattened after compression and is evidence of fiber welding / bonding that
could have occurred (Figure 14). Such cold welding of multiple fibers at numerous areas
cumulatively resulted in significantly increased stiffness observed in scaffolds subjected to
compression. Interestingly, such fiber welding is seen only in PDO:nHA scaffolds and not
in PDO scaffolds and is a common finding irrespective of the number of layers.
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Figure 14: Scanning electron micrographs of electrospun PDO scaffolds containing 50% (by wt.
of polymer) after biomimetic mineralization for 2 weeks. A&B. Compressed and non compressed
control scaffolds in de-ionized water. C- H. Compressed and non-compressed scaffolds in SBF:
C& D - 1 layer, E&F - 2 layers, G&H - 4 layers. PDO scaffolds are designated in the same format
from panel I-P. Note the discrete areas of compression resulting in cold welding of individual
fibers in all compressed scaffolds. Also note loss of continuity of individual fibers in scaffolds
treated with SBF. Cumulative effects of nano-fiber fracture might account for the decreased
stiffness observed in SBF treated scaffolds. Greater mineral content can be attributed to individual
fiber mineralization rather than mineralization on surface. This pattern also preserves the porosity
of the scaffold, important for cell infiltration.
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4.3.2. Quantification of Mineralization by ARS:
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Figure 15: Alizarin red staining of multi-layered scaffolds. Electrospun PDO and PDO:nHA scaffolds
were stacked on top of each other to get 2 or 4 layers. One group was compressed first (C1M2) and
mineralized as multilayered scaffold while the other group were mineralized as individual sheets and
compressed into a single unit (C2M1) after SBF treatment. Following incubation, scaffolds were washed
and stained for calcium using Alizarin red staining as described in the methods section. * indicates
significant difference within scaffold types (PDO and PDO:nHA) and # indicates significant difference
with compression sequence (C1M2 and C2M1).

Statistical analysis shows superior performance of PDO:nHA scaffolds compared
to PDO scaffolds in all levels. In addition, there is no statistical difference whether PDO
scaffolds were in 1, 2 or 4 layers and if they were compressed before or after SBF
treatment. Similarly, mineralization of PDO:nHA scaffolds is independent of multiple
layers. Interestingly, PDO:nHA scaffolds mineralize differently depending whether
compression was done before or after mineralization. Compression of PDO:nHA scaffolds
before SBF treatment, is identical for 1 and 2 layered scaffolds while the 4-layered
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scaffolds had superior mineralization. However, the strategy of mineralizing multiple
scaffolds separately followed by compression into a single scaffold did not yield
increasingly higher mineralization as expected. This might be partly due to difficulty of the
stain to access the interior of the multi-layered compressed scaffolds. The presence of a
non-mineralized PDO scaffold in between two mineralized layers intended for fusing
different layers might also contribute to the observations (Figure 15).
4.3.3. Mechanical Testing:
Compression of scaffolds before mineralization generally results in stiffer scaffolds. This
finding is true for both PDO and PDO:nHA scaffolds. As expected, testing samples in dry
state results in greater stiffness values compared to testing under hydrated conditions.
However the effect of hydration is more obvious in PDO:nHA than the PDO scaffolds.
Among the single layered scaffolds, non-compressed PDO:nHA was weaker than PDO but
compression of PDO:nHA scaffolds resulted in scaffolds stiffer than compressed PDO
scaffolds. In 2 and 4 layered scaffolds, compression before mineralization resulted in
stiffer compared to scaffolds that were mineralized first. Further, as long as the PDO:nHA
scaffolds were compressed before SBF treatment, increase in the number of layers resulted
in proportionally greater stiffness values. However, the PDO scaffolds did not have any
statistically significant difference whether it has two or four layers and are independent of
compression protocol (before or after mineralization).
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Figure 16: Comparison of stiffness (Young’s modulus) in multi-layered mineralized electrospun
scaffolds under dry and hydrated testing conditions. The effects of compression welding the
scaffolds are also shown. In scaffolds containing more than 1 layer, compression welding of the
scaffolds was done before SBF treatment (C1M2) or the scaffolds were mineralized separately
and then compressed at the end of 2 weeks (C2M1). NC: non-compressed, Comp:
compressed. Ctrl refers to scaffolds that were incubated in DI water while test scaffolds were
incubated in 1x r-SBF for 2 weeks.
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4.3.4. Permeability and Pore Size Measurements:
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Figure 17: Ef f ect of multi-layered electrospun scaf folds on permeability.
PDO scaf f olds were signif icantly more permeable than PDO:nHA scaf f olds
Irrespective of the number of layers. Compression predictably decreases
permeability in all scaf f olds with the exception of single layered PDO scaf fold.

The effects of compressing single or multi-layered scaffold are presented in Figure
17. It can readily be seen that compression of PDO:nHA causes a significant reduction in
permeability compared to PDO scaffolds. This finding corroborates with the SEM finding
that showed distinct areas of fiber welding seen in all types of PDO:nHA scaffolds. In
contrast, PDO scaffolds are more open and seemingly not affected by compression, at least
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on the surface. However, the permeability of single layered PDO scaffolds paradoxically
increases following compression.
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Figure 18: Effect of compression of electrospun scaffolds on pore size. Non-compressed (NC) scaffolds a
are much more porous compared to compressed ones. The porosity of single layered PDO scaffolds however
seem to be unaffected by compression. In general, pore size decreases with the number of layers the effect
being more pronounced in PDO scaffolds. Compressed single and two layered PDO:nHA scaffolds are
identical although the 4 layered ones are rendered impermeable.

In general, compression of scaffolds results in decrease in pore size of the scaffolds
with the exception of single layered PDO scaffolds that is unaffected by compression.
While the compression of single and two layered PDO:nHA scaffolds resulted in similar
reduction of pore size, the corresponding 4-layered scaffold was completely impermeable.
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4.4. DISCUSSION
Bone tissue scaffolds have to be engineered to have sufficient mechanical and
biological properties. Inorganic hydroxyapatite, that forms almost 50% of healthy bone, is
present in such high amounts to satisfy both the above mentioned criteria. It provides a
brittle, incompressible phase that is effectively dispersed and closely associated with the
tough collagenous organic phase. It is this interaction between phases having distinct
material properties that contribute to unique mechanical properties of bone.
The SEM has revealed some interesting insights into the scaffold behavior when
compressed (at 20,000 psi for a minute) at the nanoscale. There are discrete areas of
PDO:nHA scaffolds that have been pressure welded as a result of the compression process.
Interestingly, such changes are obviously missing in pure PDO scaffolds. Since the PDO
concentration was kept constant during electrospinning (100 mg/ml) for both types of
scaffolds, this behavior teases out the important role of nHA (incorporated during
electrospinning) in determining bulk material properties of the final scaffold.
The rationale of adding nHA in the present study was to provide sites of nucleation
during subsequent treatment with SBF. It was never intended to contribute to the
mechanical properties of the scaffold. Infact, the uncompressed PDO:nHA scaffold is
considerably weaker than corresponding PDO scaffolds. However, the behavior of
PDO:nHA scaffolds changes considerably under compression as shown in Figure 16. The
stiffness of compressed PDO:nHA scaffolds shows a 7-fold increase compared to noncompressed scaffolds. This observed increase in stiffness is further enhanced with the
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addition of layers, almost proportionally increasing with each layer. These findings provide
a novel strategy to improve material properties of electrospun scaffolds. Even though the
exact mechanism of improving stiffness is not clear at present, the following observations
provide further insights into this interesting behavior.
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uncompressed compressed 1
1 layer
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compressed
first- 2 layers

compressed
first - 4 layers

Figure 19: Effects of compression and multiple layers on the stiffness of electrospun PDO
and PDO:nHA scaffolds. While compression did not affect the stiffness of PDO scaffolds,
it significantly increased the stiffness of PDO:nHA scaffolds. In addition, stacking multiple
layers resulted in a proportional increase in stiffness in PDO:nHA scaffolds.

Electrospun PDO:nHA scaffolds are much less dense and has a spongy texture
compared to pure dense sheets of PDO scaffold might partially account for the behavior.
Being more compressible, PDO:nHA scaffolds deform significantly under pressure that
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ultimately would lead to welding of nanofibers. PDO, on the other hand, being dense thin
sheets, resist compression, even at the nano-scale. Further, an even compression of porous
nanofibrous structure is limited by the occurrence of finite contact points of scaffolds with
metal surfaces that are highly irregular at nanoscale.
In addition to determining the mechanical properties, these nHA containing
scaffolds are also expected to increase the amount of mineralization when soaked in SBF.
The effect of compression and addition of layers to either PDO or PDO:nHA scaffolds on
the mineral content is presented in Figure 19. Here it is obvious that compression works
against mineralization potential. Irrespective of the number of layers present,
mineralization is always better if the scaffolds are treated with SBF without compression.
Compression of scaffolds decreases the total available surface area (due to fiber welding),
makes the scaffolds denser and probably restricts mineralization to the outermost layer.
However, mineralization of multiple scaffolds followed by their compression into a single
scaffold did not yield greater mineralization outcome, at least in this study. This is most
likely due to the limitation of staining process (alizarin red not able to bind to the mineral
in the middle layers). Further, to prevent layer delamination, we adopted a strategy of
using a PDO scaffold as a sandwich between two mineralized PDO:nHA scaffolds during
their compression. It was hypothesized that the PDO will be able to flow under high
pressure and act as an adhesive bonding the two mineralized layers together. This might
have precluded contact of the stain with the mineral present within the layers.
Overall, the above experiments studied the effects of mineralization with SBF, and
compression of multiple layers. Taken together these data represent a significant increase
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in the modulus following compression of multi-layered scaffolds. But this process was
accompanied with decreased mineralization and decreased permeability. There is
essentially a middle ground between optimal mineralization and permeability vis-à-vis
improved mechanical properties. Since mechanical properties of bone scaffolds are very
critical in its function, further efforts should aim to identify methods to achieve significant
mineralization and permeability without compromising mechanical properties.
4.5. CONCLUSION
We have identified main processing parameters that affect two major properties of bone
scaffolds-stiffness and mineral content. Use of high pressure to weld nanofibrous scaffolds
greatly improves material properties while incubation of electrospun scaffolds in 1x r-SBF
provides a convenient and physiological means to improve mineralization of scaffolds in
vitro. Compression of electrospun scaffolds at very high pressure resulted in
significantly higher levels of stiffness of PDO:nHA scaffolds compared to controls. In
addition, this technique also permitted stacking of multiple independent electrospun
scaffolds on top of each other without fear of delamination. On the other hand, such an
approach, limits the amount of mineralization following treatment with SBF due to loss of
available surface area. A 4-layered PDO:nHA scaffold compressed first followed by
mineralization in r-SBF has maximal stiffness with the mineralization second only to noncompressed scaffolds. Within the limitation of this study, this scaffold configuration
represents an optimal midway for desired stiffness and mineral content.
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Chapter 5: QUANTIFYING BIOMATERIAL CYTOCOMPATIBILITY
VIA IN-CELL ASSAY OF PHOSPHOVINCULIN (pY-822)

Preface: The following chapter has been submitted to Journal of Biomedical Material
Research and is under review.

80

5.1. ABSTRACT

Cell adhesion is a causal event that dictates the eventual global host response to
biomaterial implantation including its integration and sequestration. Cell proliferation,
function and differentiation are processes that occur secondary to cell adhesion. Cell
adhesion to native extracellular matrix (ECM) or any biomaterial is mediated via integrin
binding to the adsorbed protein layer occurs at discrete areas on the cell membrane called
focal adhesions. These focal adhesions are multi-protein complexes that modulate insideout and outside-in signaling between the cell and ECM and play a critical role in
determining the implantation outcomes. Since focal adhesion formation is the molecular
event underlying cell adhesion, we reasoned that quantifying focal adhesions would enable
us to predict the cytocompatibility of a biomaterial surface. Vinculin is a cytoplasmic
protein that gets phosphorylated upon activation and one form of phosphovinculin, pY822, has been identified to be enriched at focal adhesions. In this study, we analyzed the
expression of vinculin and phosphovinculin (pY-822) by osteoblast-like MG-63 cell lines
after seeding them onto different substrates including collagen, gelatin, fibronectin, tissue
culture treated plastic and untreated plastic. Western blotting experiments indicated that
phosphovinculin is absent in circumstances that are not conducive to focal adhesion
formation (cells grown on untreated plastic) while vinculin was detected in all
circumstances, even in a non-adherent environment. Confocal microscopy demonstrated
co-localization of both vinculin and phosphovinculin at focal adhesions and confirmed the
specificity of the antibodies used. Further experiments using In-Cell Western assay

81

allowed quantification of these molecules irrespective of surfaces or time points studied.
Using the above evidence, we propose an improved functional yet quantitative assay of
biomaterial cytocompatibility, exploiting the sensitivity of infrared imaging and specific
association of phosphovinculin to focal adhesions.
5.2. INTRODUCTION

The focus of biomaterial research is shifting from the structural replacement of
diseased or missing tissues in favor of functional organ regeneration. Such a shift in design
paradigm has resulted in the development of a new generation of biomaterials. However,
the ultimate challenge in biomaterial design and development lies in achieving biointegration without eliciting any adverse host reactions. Critical to successful integration is
the ability of the implant to recruit, retain and facilitate the function of cells native to the
tissue or organ it aims to regenerate. A number of important in vitro assays (physical,
mechanical, chemical, electrical) have been optimized to characterize biomaterials based
on their application. Biological performance of materials are being increasingly scrutinized
at microscopic, molecular and genetic levels in an effort to appreciate and better
understand cell-biomaterial interactions [154-155]. Recent advances in cell signaling and
molecular biology have increased our understanding of the events underlying cellbiomaterial response. Unfortunately, this knowledge has not translated into development of
more sophisticated in vitro assays that would permit biological characterization of
biomaterial surfaces [156].
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Cell adhesion to the extracellular matrix not only provides vital survival cues but is
also necessary for proliferation, differentiation and maintenance of phenotype [157-161].
Cells possess heterodimeric transmembrane receptors called integrins, capable of binding
to a wide variety of extracellular ligands. This binding initiates formation of focal
adhesions - discrete spots on the cell membrane where components of ECM, integrins and
cytoskeleton are in close proximity. Integrin mediated focal adhesions not only establish
physical continuity but also mediate inside-out and outside-in signaling pathways that
underlie the dynamic reciprocity of the cell-ECM interactions [162, 163]. Since cell
adhesion is a primary event that modulates subsequent responses, an assay of cell adhesion
will reflect a material’s cytocompatibility [164] and quantifying adhesion would be of
predictive value in assessing the in vivo performance of biomaterials [165, 166].
Experimental methods to quantify cell adhesion have been mostly indirect, based
on the ability of cells to resist shearing forces by washing, centrifugation and
hydrodynamic shear [167]. Repeated washing, though simple and rapid, is difficult to
quantify and lacks reproducibility. While centrifugation assay provides a uniform
detachment force, they are relevant only within a narrow window of time (within 60 min)
[168]. Hydrodynamic flow assays or micromanipulators are more accurate in determining
adhesion but require specialized instrumentation. Assessment of molecules that participate
in focal adhesions can provide a direct quantitative measure of cytocompatibility of
biomaterials [156]. Since the focal adhesion is a complex of more than 50 different
proteins, our objective was to identify a reliable marker and then use it to develop a
quantitative assay of cytocompatibility in vitro. Vinculin is a well known cytoplasmic
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protein that is recruited to focal adhesions upon activation by multiple mechanisms
including phosphorylation. Even though vinculin can be phosphorylated at more than one
site, phosphovinculin (pY-822) is being shown to represent a specific subset of vinculin
that are particularly associated with focal adhesions. In the present study, we introduce a
new infrared based detection technique to quantify the expression of phosphovinculin (pY822) that can be used as a tool to evaluate the cytocompatibility of biomaterials.
5.3. MATERIALS AND METHODS

All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless stated
otherwise.
5.3.1. Cell Culture:
Human osteoblast-like cells MG-63 were purchased from ATCC (American Type
Culture Collection, Manassas, VA) for the study. The cells were cultured in Dulbecco
Modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and 1%
penicillin–streptomycin (Cat # 15140-122) from GIBCO.
5.3.2 Coating Cell Culture Dishes:
Five different substrates for cell culture were used for the study: a. untreated culture
plastic (Cat # 08-772-31, Fisher Scientific, PA), b. cell culture treated polystyrene (Cat #
08-757-168, Fisher Scientific, PA), c. collagen, d. gelatin and e. fibronectin. Circular 60
mm dishes (for western blotting experiments) or 96 well plates (for in-cell western assay)
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were used as is or after coating with the extracellular matrix proteins using the protocol
described below.
Purified bovine type I collagen was purchased as liquid Purecol at 3 mg/ml
(Inamed, Fremont, CA). This solution was diluted with sterile PBS to a final concentration
of 0.01% (wt/vol). Powdered bovine gelatin (Cat #: G9391, Sigma, MO) was dissolved in
sterile water to a final concentration of 0.05% (wt/vol). Sterile, endotoxin-free, lyophilized
human fibronectin (Cat #: 356008, Collaborative Biomedical Products, Bedford, MA) was
dissolved in sterile water at 1 mg/ml concentration by gentle swirling until a clear solution
was obtained. This solution was filter-sterilized and further diluted with sterile PBS to a
final concentration of 50 µg/ml.
For coating, respective solutions were poured into tissue culture dishes till the
solutions were 2 mm in depth and left overnight at 4oC. Excess solution was aspirated and
dishes left to dry under a laminar flow hood. The dishes were washed thrice with PBS
before cell seeding.
5.3.3. Confocal Microscopy:
MG-63 cells were seeded on glass cover slips at a density of 400 cells/mm2 and
cultured in DMEM with 10% FBS. Cells were allowed to attach to the glass surface for 24
hours and fixed with freshly prepared 2.5% paraformaldehyde (pH 7.5). Cells were
permeabilized with 0.1% Triton X-100 for 5 minutes on ice and probed with antibodies
against total vinculin (1:100 dilution) and phosphovinculin (pY-822) (1:25 dilution).
Alexafluor labeled secondary antibodies (Invitrogen) raised against mouse (633 nm) and
rabbit (488 nm) were incubated in the dark for half an hour. After washing, cover slips
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were mounted on glass slides using ProLong Antifade (Invitrogen) mounting medium
containing DAPI. The slides were analyzed using a Zeiss 510 Meta confocal imaging
system.
5.3.4. Cell Density Quantification:
The DNA of the cells was first labeled using a cell permeable anthraquinone dye,
Draq 5 (Biostatus Ltd, Leicestershire, UK) that fluoresces at 700 nm. Formaldehyde fixed
cells were treated with 5 mM Draq 5 solution diluted in PBS and incubated for 10 minutes
at 37°C. After washing to remove unincorporated dye, the plates were read directly at 700
nm using Odyssey Imaging System to measure fluorescence emitted by the intercalated
labeled DNA. The resulting fluorescence was used as a measure of cell density.
5.3.5. Western Blotting:
All cell culture experiments were done in triplicates for each time point (1, 3, 6, 9,
24 hours). MG-63 cells were grown in T-150 flasks to confluence, detached with 0.25%
trypsin and seeded at a density of 106 cells/dish. At each time point, cell lysate was
collected in cold lysis buffer (20 mM Tris, pH 7.4, 50 mM NaCl, 1 mM EGTA, 5 mM
EDTA, 50 mM sodium pyrophosphate, 50 µM sodium fluoride, 100 µM sodium orthovanadate, 1 µl/ml protease inhibitor cocktail, 0.5% Triton X-100 and 0.1%
phenylmethylsulfonylfluoride). The lysate was vortexed briefly and allowed to stand at
4°C for 15 minutes then centrifuged at 1,000g for 10 minutes. The supernatant was
collected and stored at -70oC. An aliquot of the lysate was used for protein quantification
to ensure equal loading in the gel. Appropriate amount of the lysate from the samples were
diluted in laemmli sample buffer, boiled for 5 minutes, loaded onto a Criterion 10% Tris86

HCl gel (Biorad) and electrophoresis performed at 100 volts under reducing conditions.
The proteins were then transferred onto a PVDF membrane (Millipore, Bedford, MA) and
reversibly stained with Ponceau S to ensure complete transfer. The membranes were then
blocked with Odyssey blocking buffer (Licor Biosciences, Lincoln, NE), probed with
primary antibodies for vinculin (mouse anti-human) and phosphovinculin (rabbit antihuman) at 1:1000 dilution for 1 hour at room temperature. The secondary antibodies,
conjugated with dyes that fluoresce at 700 and 800 nm, were diluted in the blocking buffer
(1:20000 dilution) and incubated with the membrane for 30 minutes in a light proof box.
After extensive washing, the membranes were scanned with the Odyssey imaging system
(Licor Biosciences, Lincoln, NE) at specified wavelengths and resulting fluorescence
recorded.
5.3.6. In-Cell Western (ICW) Assay:
Tissue culture grade microtiter (96 well) plates were used as is or coated with
different proteins as described above. MG-63 cells were grown in 150 mm dishes until
confluence and collected with 0.25% trypsin. The cells were counted, diluted in fresh
media and seeded at 15, 30 or 45x103 cells/well. At every time point specified (1-48
hours), cells were fixed with 10% formalin for 20 minutes at room temperature. The cells
were then washed thrice with 25 mM glycine (containing 1% bovine serum albumin) for 5
minutes each, permeabilized with 0.1% Triton X-100 and blocked with Odyssey Blocking
buffer for an hour at room temperature. Vinculin and phosphovinculin specific primary
antibodies were diluted 1:1000 in the blocking buffer and the cells were incubated for an
hour at room temperature. After washing, cells were incubated for 30 minutes with anti87

rabbit (1:1000 dilution) and anti-mouse (1:500 dilution) fluorescent dye coupled secondary
antibodies (excitation 800 nm). The plates were optically scanned at 800 nm, the
fluorescence intensity recorded and quantified.
5.3.7. Statistical Analysis:
All experiments were performed in triplicates and data analyzed using JMP 7.0
(SAS, Cary, NC). Analysis of Variance (ANOVA) was performed and the means were
compared using the multiple comparisons Tukey-Kramer test to detect any statistical
difference (α = 0.05) in the expression levels of phosphovinculin or total vinculin. The data
is presented as means and standard errors.
5.4. RESULTS

5.4.1. Immunohistochemical Staining:
The cells were stained for vinculin, phosphovinculin and DAPI to demonstrate the
specificity of the antibodies used and the distribution of the molecules under study. Both
the antibodies used bound specifically to their target molecules as can be seen by
negligible background fluorescence at corresponding wavelengths. The confocal images
clearly illustrate the formation and positively stained focal adhesions on the cell
membrane. As expected, both vinculin and phosphovinculin are enriched at focal
adhesions and these molecules co-localize (Figure 20).
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Figure 20: Confocal microscopic images showing co-localization of vinculin and
phosphovinculin at focal adhesions. Top: A composite confocal image of MG 63 cells grown on
tissue culture plastic stained for nuclear DNA (DAPI), vinculin and phosphovinculin. Focal
adhesions are readily seen as discrete spots on the periphery of the cell. Bottom: A close-up
view of the focal adhesions in a selected area of the cell membrane. The images obtained from
each laser is separated to demonstrate specificity of the signal and co-localization of vinculin
(red) and phosphovinculin (green) at focal adhesions. Left panel shows vinculin at 633 nm,
middle phosphovinculin at 488 nm and the right panel is a composite image (yellow).

5.4.2. Cell Density Measurement:
As expected, there is a corresponding increase in the staining intensity with an
increase in the cell number. This increase does not appear to be linear and tend to plateau
off at 45x103 cells/well (Figure 21). This is probably due to saturation of the signal in this
channel. This finding supports the fact that Draq staining of the DNA and measuring the
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fluorescence with Odyssey Infrared scanner can be reliably used to quantify cell density. A
plot of draq-5 fluorescence versus time reveal no appreciable increase up to 6 hours while
the fluorescence intensity shows a significant increase at 9 and 24 hours, corresponding to
the presence of mitotic numbers due to asynchronous cell cycle progression in culture.
Further, as expected, the substrate on which cells were seeded did not significantly affect
the cell replication at least within the short period of time (24 hours). Figure 19 shows a
representative data from the sample taken at 9 hours, at which significant increase in DNA
was observed.

Figure 21: Quantification of DNA using Draq5. A. Standard curve showing increasing
fluorescence with increasing cell density in a 96 well plate format. Saturation of the signal occurs
3
at 45x10 cells/ well. B. shows no significant increase in cell numbers at early time points till at 9
hours due to asynchronous cell cycle. C. demonstrates no significant differences in the cell
numbers at 9 hours when cells are seeded on different surfaces.

5.4.3. Western Blotting:
Samples from each time point and surface were run in 10% polyacrylamide gels as
described. Figure 22 is a representative western blot of samples that demonstrates the
specificity of antibodies and the pattern consistently seen in all the blots. Blots developed
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for vinculin (A) showed two bands: a faint 150 KDa band and well defined 130 KDa band.
The phosphovinculin blot (pY-822) in (B) detects one unique band at 130 KDa.
Phosphovinculin was absent in cells grown on untreated plastic while it was detected in
cells cultured on any other dishes. Vinculin, on the other hand, consistently showed up in
all the lanes including cells from untreated plastic, though its intensity was consistently
less than in cells grown on adhesion-conducive surfaces. Differences in the intensity of
vinculin or phosphovinculin bands across different time points and surfaces were
insignificant and could not be quantified with accuracy (hence not shown).
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Figure 22: Western Blot of cell lysate from MG 63 cells cultured for 24 hours on ECM
protein (collagen, gelatin and fibronectin) coated surfaces, tissue culture polystyrene
and non tissue-culture grade plastic surface (control). The blot in A was developed for
vinculin and phosphovinculin (130 KDa, indicated by arrow) in B. While vinculin is
expressed in all surfaces including non tissue-culture grade plastic, phosphovinculin is
expressed only on surfaces conducive for focal adhesion formation. The 150 KDa
fragment detected in A corresponds to meta-vinculin, an alternatively spliced variant of
vinculin.

5.4.4. In-Cell Western Assay of Vinculin and Phosphovinculin as a Function of Cell
Number:
A plot of vinculin against increasing cell numbers grown in tissue culture plastic
shows a saturation effect similar to that observed for Draq 5 at high seeding densities.
Phosphovinculin expression on the other hand, shows a highly linear relationship with
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increasing cell density. This shows that phosphovinculin can be used as molecular marker
for the study of focal adhesions even at high seeding densities, at least when infra red
imaging is used as the tool for study (Figure 23).
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Figure 23: Plots of vinculin (left) and phosphovinculin (right) expression as a function of cell numbers at
9 hours on tissue culture plastic. Expression of vinculin is not only high compared to phosphovinculin
(labeled p vin) but also shows saturation at high cell numbers similar to that observed with Draq5.
Phosphovinculin, on the other hand, show a perfectly linear expression profile even at high numbers.
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Having demonstrated that phosphovinculin expression is linear over the range of
cell densities when cells are cultured in TCPS, our next effort was to study its expression
on different surfaces. The results show a linear relationship of phosphovinculin expressed
as a function of cell number in all types of surfaces studied (R2>0.99 in all surfaces)
(Figure 24).
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Figure 24: Phosphovinculin expression as a f unction of cell number cultured
On dif f erent surf aces f or 9 hours. As expected, the number of cells used in (30x103)
f alls within the linear detection range of phosphovinculin f or all surf aces studied.
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5.4.5. In-Cell Western Assay of Vinculin and Phosphovinculin as a Function of Time
within Surfaces:
Expression levels of total vinculin in Figure 25, shows it reaches a steady state at
around 24 hours and does not appreciably change even after 48 hours. Similarly there is no
significant difference within early time course (1-4 hours) after cell seeding onto any type
of surfaces. Interestingly, these values always drop from 3 hours to 4 hours before showing
an increase at 6 hours suggesting a very dynamic turnover of these proteins during initial
adhesion and spreading.
Expression levels of phosphovinculin shows an interesting trend: there is single
peak intensity at one specific time point for each of the surfaces studied that is statistically
significant from other surfaces. Cells grown on TCPS show a maximum expression at 4
hours, those grown on collagen at 6 hours, gelatin at 24 hours and fibronectin at 24-48
hours. This finding suggests that different kinetics for focal adhesion formation exist when
cells are seeded onto different matrix proteins and cells modulate their adhesion, spreading
and motility differently according to their immediate environment.
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Figure 25: In-cell western assay of changes in expression of total vinculin and
phosphovinculin over time on any given surface. A. shows the signal from total vinculin
(meta-vinculin and vinculin) plateau off around 24 hours and does not change even after 48
hours. Cells grown on collagen, however reached the plateau as early as 6 hours. Groups
connected by bars are similar and * denotes significant difference (α =0.05) between the
groups. B. reveals an interesting pattern of expression of phosphovinculin. Each surface
shows a characteristic time point at which the expression is maximal and statistically
significant (indicated by *) from other surfaces.

5.5. DISCUSSION
The immediate consequence of implantation of biomaterial in vivo is the adsorption
of proteins including albumin, fibronectin and fibrinogen. Different biomaterials adsorb
proteins differently and ultimate host response depends to a large degree on specific
adsorption profile. Cells bind to the adsorbed protein layer through integrins and adhesion
occurs at discrete points called focal adhesions. A large complex of structural and signaling
proteins assemble at these sites and serve as a functional link between the cell and the
ECM [169, 170]. Since host response to a biomaterial is mediated through the formation of
focal adhesions, quantification of molecules that directly participate in these structures is
logical and presents a relevant measure of cytocompatibility. Even though the list of
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proteins that assemble at focal adhesions is growing, integrins, talin, vinculin, paxillin and
actinin are perhaps the most studied.
Integrins initiate formation of focal adhesions by binding to the matrix proteins on
the extracellular domain and recruiting multiple proteins to form supra-molecular
assemblies on the cytoplasmic side. Integrins are composed of an alpha (α) and a beta (β)
chain that assemble together to form a heterodimeric complex. They comprise a huge
family of proteins assembled from 18 different α chains and 8 distinct β chains that
dimerize to form a functional receptor. Integrin binding to ECM ligands can be unique
(one integrin type can bind to only one ECM ligand), overlapping (one integrin type can
bind to multiple ligands) or redundant (more than one integrin type can bind to one ligand)
[162]. Thus even though integrins are the prime component of any focal adhesions and
may seem to be the obvious choice, they are also very poor molecular targets to study nonspecific focal adhesions as in this study.
When cells come in contact with an implanted biomaterial, they ‘see’ the
biomaterial through the adsorbed protein layer. The patterns of adsorption of various serum
and extracellular fluid proteins and their conformation change differ with the type of
biomaterial. If the biomaterial is favorable, the adsorbed protein profile and conformations
will facilitate binding of integrins and eventual cell adhesion. Adsorption of serum proteins
on an unfavorable surface can be accompanied by varying degrees of denaturation and if
severe, can render integrin binding impossible. Thus, the adsorbed protein layer is to the
cells what a stick is to the blind. Integrin binding to a favorable ligand (protein adsorbed to
a friendly biomaterial surface) is followed by clustering of more integrin receptors on the
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cell membrane that eventually trigger recruitment of specific cytoplasmic proteins to form
focal adhesions. Vinculin is one such cytoplasmic protein that gets activated and recruited
to focal adhesions irrespective of the integrin isotype that initiate the process. Such
activation and recruitment of cytoplasmic proteins represents a common pathway of focal
adhesion formation which is independent of type of integrin binding or the ECM ligand.
Thus these cytoplasmic proteins can be reliably and easily used as a marker of focal
adhesions and offer a unique opportunity to study them. Since vinculin is a constitutive
cytoplasmic protein that gets activated to be recruited to focal adhesions, we reasoned that
quantifying activated form of vinculin can serve as a reliable marker of focal adhesions and
be used to characterize biomaterial cytocompatibility.
Vinculin is a multi-domain scaffolding protein composed of a globular head
(domains D1-D4) and an elongated tail (D5) connected by a flexible proline-rich neck. D1D3 of the head binds to talin, actinin and catenin, the neck to vinexin, ponsin, VASP and
Arp 2/3 complex while the tail binds to F-actin, protein kinase C [171] and acidic
phospholipids [172]. Vinculin can exist in at least two conformation states-active and
inactive. The multiple binding domains on vinculin are masked by a strong head-tail
interaction in the inactive state while these domains are free to interact in the active form.
Recent evidence has shown that the resting inactive state is cytosolic while the active form
gets recruited to the focal adhesions. The mode of activation of vinculin is still unclear.
Evidence exists that the event is combinatorial. Activation occurs (1) when two or more of
its binding partners are brought into close apposition [173], (2) secondary to
phosphorylation,[174, 175], (3) through PIP-2 binding [176], or (4) a combination of
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events [177]. Even though vinculin has more than one phosphorylation site, pY-822 has
also been implicated in its activation. Irrespective of the mechanism, once activated,
vinculin gets recruited to focal adhesions where it also contributes to adhesion
strengthening [178, 179]. A study of F9 vinculin (-/-) cells showed that a single mutation
of tyrosine residue (Y-822) markedly reduces the stiffness and elasticity (secondary to
defective focal adhesion formation) compared to the F9 wild-type [180]. Since
phosphorylation is one of the many events in activating vinculin, we chose to study
phosphovinculin (pY-822) as a marker of focal adhesions.
Quantifying focal adhesions in an in-cell format using infrared fluorescence
improves accuracy because it permits detection of target molecules an in situ context in a
spectrum where autofluorescence is greatly reduced. The sensitivity of the technique
coupled with the specificity of the antibody, improves accuracy of quantification and
reliability of the assay.
Since the basis of quantification in ICW assay is the amount of fluorescence, it
becomes imperative that the antibodies used are specific to the molecules of interest.
Therefore, the Western blots are necessary to validate the assay. The vinculin antibody was
developed against the full length native protein while the phospho-antibody was specific
for epitope adjacent to tyrosine residue at position 822 (pY-822). Western blots (Figure 22)
from representative lysates of cells grown on different substrates and probed with vinculin
and phosphovinculin antibodies demonstrate that pY-822 phosphovinculin antibody was
specific to 130 KDa protein while vinculin antibody detected two proteins. The higher
molecular weight protein (150 KDa), detected by vinculin antibody is most likely meta98

vinculin, an alternatively spliced variant of vinculin, with which it is immunologically
related [181, 182].
Interestingly, phosphovinculin (pY-822) was absent in cells cultured on untreated
plastic, surfaces that are not conducive for the formation of focal adhesions. Cells grown
on surfaces that favor adhesion and spreading (collagen, gelatin, fibronectin and TCPS)
consistently showed phosphovinculin. On the other hand, vinculin was detected
irrespective of whether the cells attach to the surface or not. This finding is consistent with
the fact that vinculin is a constitutive cytoplasmic protein, only a fraction of which gets
activated and recruited to focal adhesions. Thus our rationale for proposing and using
phosphovinculin as a specific molecular marker of focal adhesions is validated.
In addition, any assay that use an antibody to full length vinculin is misleading
because of the non-specificity of the antibody: it can bind to auto-inhibited native vinculin,
activated vinculin and meta-vinculin, representing the total pool of vinculin. This is an
important limitation in quantitative assays that involve the use of antibodies.
Data from the ICW assay of cell adhesion using phosphovinculin (pY-822) as a
marker allows us to follow the dynamics of focal adhesion formation on different surfaces.
Cells adhesion was best on TCPS at 4 hours, while collagen surfaces elicited maximal
expression of phosphovinculin at 6 hours. Cells grown on gelatin and fibronectin surfaces
showed maximal adhesion during the late time frame (24 - 48 hours).
Differences in matrix composition and protein adsorption profile have been known
to control cell adhesion, proliferation and differentiation of mesenchymal stem cells in
vitro. Chastain et al. provided evidence for the hypothesis that integrin-mediated cell
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adhesions to scaffolds controlled the differentiation of mesenchymal stem cells in vitro
[183]. One possible mechanism could be that different signaling pathways can be activated
by binding of different types of integrins to different proteins. It must be remembered that
focal adhesion formation is not only a function of biomaterial surface but also depends on
the cell type and time. The aim of the present study is to develop a reliable assay that
would enable us to follow the kinetics of focal adhesion formation irrespective of the
surfaces, time points or the cell types of interest. Future studies could examine signaling
pathways involved in cell adhesion to different matrix proteins and possibly account for
the difference in kinetics observed.
5.6. CONCLUSION
The present study was successful in identifying phosphovinculin (pY-822) as a
reliable and quantifiable molecular marker of focal adhesions irrespective of biomaterial
surface studied. Use of total vinculin to quantify focal adhesions is compromised by the
presence of multiple isoforms and different conformation states. Phosphovinculin
represents a subset of vinculin molecules that undergo activation and are recruited to focal
adhesions. These molecules are not expressed when no focal adhesions form, thus iterating
their specific association with focal adhesions. ICW assay for phosphovinculin, proposed
in this study, provides a simple yet accurate quantitative technique to follow the kinetics of
focal adhesion formation when traditional assays have proven difficult. The penetrative
ability of infrared rays further expands the scope of the assay to characterize
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cytocompatibility of 3D tissue engineering scaffolds by their ability to induce cell adhesion
and migration.
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Chapter 6: EFFECTS OF EXPOSURE OF BMP-2/7 TO VOLATILE
ORGANIC SOLVENTS USED IN ELECTROSPINNING

6.1. INTRODUCTION
Bone is one of unique organs in the adult body that retains a remarkable ability to
undergo complete regeneration following injury, as evident in healing following fractures.
Bone at the site of fracture, once healed, is virtually indistinguishable from the neighboring
normal bone both in terms of histology and mechanical properties. However, there are
conditions, where the inherent healing capacity of bone falls inadequate and in these
circumstances, external intervention in terms of grafting becomes necessary. Autografts
(current gold standard) and allograft have the ability to form new bone following grafting.
This is due to couple of independent yet interrelated phenomena: osteoconduction and
osteoinduction [184]. While the former refers to the ability of the graft to permit (by acting
as a passive template) new bone formation, the latter refers to actively inducing cells to lay
down new bone matrix. The process of osteoinduction is exemplified by a group of
proteins called bone morphogenetic proteins (BMPs) that reside in extremely small
amounts in the organic (non-collagenous) matrix of the bone. These highly potent
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molecules are capable of inducing new bone where there are none (subcutaneous and
intramuscular sites) or at normal bony sites. It is important to bear in mind that the cellular
events following fractures is essentially a recapitulation of the processes associated with
embryonic bone development. It should be no surprise that BMPs play a definitive role in
fracture repair.
Since its discovery and isolation in 1960s, more than 20 members of BMP family
have been identified. The most relevant BMPs in bone research are BMP-2 and BMP-7.
Both these are very potent molecules that have been approved for clinical use in specific
orthopedic application. BMPs are comprised of two identical chains, each with seven
highly conserved cysteine residues. While six of them contribute to an intrachain cysteine
knot, the seventh cysteine from each chain participates in the interchain disulfide linkage to
form a dimer. BMPs associate to form dimers, bind receptors, activate Smad signaling
pathway to regulate a variety of genes including cbfa1 and inhibitor of differentiation (Id14) [185, 186]. Mouse Id-1 promoter responds selectively to BMPs and not to TGFβ
signaling [187, 188]. Even though homo-dimers of BMP-2 or 7 have been used to induce
osteoblastogenesis, recent research indicate that the hetero-dimer of 2/7 is significantly
more potent than either of homodimers [189, 190] and hence will be used in this study.
6.2. MATERIALS AND METHODS:
BMP-2, BMP-7 and BMP-2/7, monoclonal antibody to BMP-2/7 heterodimer were
purchased from R&D Systems (Minneapolis, MN). The slot-blot apparatus and the
nitrocellulose membrane were purchased from Bio-Rad Laboratories (Hercules, CA).
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Odyssey Imaging System, blocking buffer and the secondary antibody (goat anti-mouse IR
800 CW) were from LiCor Biosciences (Lincoln, NE). C2C12BRA cells were a kind gift
from Dr. Daniel Rifkin, New York University School of Medicine, New York, NY 10016,
USA.
6.2.1. Serial Dilutions of BMPs and Detection by Slot-Blotting:

All serial dilutions were performed in 1:2 ratios in solubilization buffer (4 mM HCl
and 0.1% BSA), unless otherwise noted. The nitrocellulose membrane was wet in TBS for
10 minutes before the experiment and immobilized in Bio Dot Microfiltration Apparatus
under vacuum. Samples were loaded on the template wells and protein solution allowed to
drain by gravity through the nitrocellulose membrane. Once filtration was complete, the
membrane was removed from the apparatus, washed thrice in 0.1% TBS-Tween for 5
minutes each and blocked for an hour at room temperature. Incubation with the
monoclonal primary antibody against the heterodimer (1:1000 dilution) was carried out at
4°C overnight. After extensive washing, the membrane was incubated with infraredsensitive secondary antibodies (1:10000 dilution) for 30 minutes at room temperature in a
light proof container. The membrane was scanned by Odyssey Imaging System at 800 nm
wavelength and fluorescence recorded.
6.2.2. Sensitivity and Specificity of the Slot-Blot Assay to BMP-2/7:
Serial dilution of BMP- 2/7 was set up in 1:2 ratios starting from 1 µg (1000 ng) to
obtain the range of detection by infrared imaging. Since BMP -2/7 is a heterodimer of
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BMP 2 and BMP 7, our next effort was to determine the specificity of binding of the
antibody to different BMPs. As described in the earlier section, a 1:2 serial dilution was
performed of BMPs 2, 7 and 2/7 (with a starting concentration of 500 ng) in buffer and
fluorescence detected.
6.2.3. Exposure of Organic Solvents to BMPs:
Since one of the main critiques of electrospinning tissue engineering scaffolds has
been the use of volatile and potentially denaturing organic solvents, an experiment was set
up to study the effects of commonly used solvents on BMP-2/7. The solvents used
(hexafluroisopropanol-HFP, trifluroethanol-TFE, trifluroacetate-TFA) for serial dilutions
were either undiluted or diluted by 50% with buffer to investigate whether increased
polarity of the solvent would be beneficial. 100 ng of BMP-2/7 was dissolved in fresh
buffer or in solvents, and serial dilutions performed. The plates were left to dry under the
hood overnight. The BMP was then re-solubilized in 100 µl of fresh buffer and dot-blotted
onto a nitrocellulose membrane and developed for fluorescence as described.
6.2.4. Electrospinning BMP-2/7 and Characterizing its Release:

For controlled release experiments, 10 µg of BMP-2/7 was dissolved in 100 µl of
buffer and added to 3 ml of PDO, PDO: nHA at 100 mg/ml concentration and nHA at 50%
by wt of polymer. After mixing, the solutions were electrospun at 3 ml/hr, 26 kV for nHA
containing solutions and 28 kV for pure PDO and the scaffolds collected on a mandrel of
dimensions 7.5 x 1 x 0.5 cm. Dry scaffolds were cut into 6mm discs using a dermal biopsy
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punch. The discs were placed in 100 µl of PBS and incubated at 37°C and 5% CO2. The
PBS was replaced at 1, 3, 6, 12, 24 hours and 2, 3, 4, 5, 7 and 14 days with 100 µl of fresh
solution. All solutions were stored at -20°C till analysis. Samples were thawed to room
temperature and slot-blotted onto nitrocellulose as described before.
6.2.5. Characterization of Biological Activity of BMPs on C1C12BRA cells:
C1C12BRA are specialized embryonic myoblast cell lines that have been stably
transfected with a luciferase reporter plasmid consisting of BMP-responsive elements from
the Id-1 promoter that is highly specific to BMP signaling and not any members of TGF-β
family. It provides a powerful, highly sensitive and cell based assay for quantification of
BMP activity. The peak luciferase activity has been found to occur 10-15 hours following
exposure to BMPs [191]. These cells were cultured to 90% confluence in a T-75 flask in
DMEM media containing 10% FBS and 1% penicillin and streptomycin. The cells were
harvested with 0.25% trypsin, divided into equal aliquots and centrifuged to a pellet. Cells
were then resuspended in either serum-free or serum-containing media and seeded in 6
well plates. After allowing adequate time for attachment and once they are at least 80%
confluent, BMP-2, BMP-7 and BMP-2/7 in buffer was added in four different
concentrations of 0.1, 1, 10 and 100 ng/ml. Control wells received an equal volume of
buffer. The plates were returned to the incubator for a period of 10 hours. At this time,
cells were washed twice with PBS and the lysate collected in 100 µl of cold reporter lysis
buffer (Promega). The lysate was centrifuged at 1200g for 10 minutes and supernatant
transferred to a new tube. Protein quantification (Bradford assay) of the lysate was
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performed and the volumes normalized to ensure equal protein concentration. 20 µl of this
sample was added to 100 µl of luciferase reagent and luminescence measured with a
luminometer (Eppendorf, Westbury, NY).
6.2.6. Effect of Organic Solvents on the Biological Activity of BMP-2/7:
The experiment was carried out in a 6-well plate format in triplicate. C2C12 BRA
cells were cultured in DMEM with 10% FBS with 1% penicillin-streptomycin until they
were at least 90% confluent. 60 µl of BMP-2/7 (containing 60 ng) was mixed in a variety
of organic electrospinning solvents- HFP, TFE, TFA, each either at full concentration or
diluted in half with buffer to make it more polar. The plates were incubated at 37°C till dry
and when the BMP was reconstituted in 60 µl of buffer. Each test well containing cells
received 20 µl of reconstituted BMP-2/7 for every ml of media while control wells
received an equal amount of BMP-2, BMP-7 or plain buffer. The luciferase activity was
recorded as described above.

6.3. RESULTS
6.3.1. Sensitivity of the Assay:

The results from the slot-blot experiments are presented in Figure 26. There is an
excellent correlation between the concentration of BMP-2/7 and the detected fluorescence.
Thus the process parameters have been successfully optimized to enable reliable detection
of BMP-2/7 using infrared imaging. The conservative limit of detection of BMP in this
method was 15 ng.
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Figure 26: Slot-blot experiment to validate detection and quantif ication of BMP-2/7.
A 1:2 serial dilution was made in buf f er and blotted onto a nitro cellulose membrane.
The membrane was probed with heterodimer specif ic antibody f ollowed by incubation
with f luorescent dye tagged secondary antibody. The membrane was scanned with
inf rared rays and f luorescence quantif ied. Lower panel shows the actual scan image

6.3.2. Specificity of the Assay to BMP-2/7:
The results (Figure 27) indicate a very high binding specificity of the antibody to
BMP-2/7 heterodimer. The antibody did not bind to BMP-2 or BMP-7 even at very high
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concentrations (500 ng). The fluorescence detected for BMP-2, BMP-7 and control lanes
having no BMP is identical and remains flat throughout the range of dilutions.
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Figure 27: Slot blot experiments demonstrating specificity of the antibody to the dimeric
form of BMP. Serial dilutions of BMP-2, BMP-7 and BMP-2/7 were made in buffer
and blotted onto a nitrocellulose membrane. While the BMPs 2 and 7 were identical
to buffer (control), BMP-2/7 gave a strong and specific signal.
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6.3.3. Effect of Organic Solvents on BMPs:
The BMP-2/7 heterodimer consists of BMP-2 and BMP-7 held together by
disulfide bonds and the antibody used is highly specific to the dimeric form of the BMP
and does not recognize either of the monomeric forms of BMP. The heterodimeric BMP
was exposed to an excess of organic solvents, in a period of time similar to that used in
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Figure 28: Effect of organic solvents on denaturation of dimeric form of BMP-2/7.
Serial dilutions of the BMP was made in a variety of organic solvents and slot blotted
onto nitrocellulose membrane. Results show no significant denaturation of the dimer
when BMP is exposed to organic solvents. Dilution of solvents with aqueous buffer
provided no benefit.
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electrospinning. In spite of this exposure to harsh environment, the data shows no
difference from BMPs in buffer (Figure 28). There is no evidence of dissociation of the
heterodimer or protein denaturation sufficient to cause loss of epitope. These data suggest
that exposure of BMP-2/7 does not result in denaturation of these biologically active
molecules.
6.3.4. BMP-2/7 Release from Electrospun Scaffolds:
The data for release kinetics up to 2 weeks does not reveal anything dramatic
(Figure 29). There is no difference in the release profile for either the PDO or PDO:nHA
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Figure 29: Release kinetics of BMP-2/7 from electrospun PDO (A) and PDO:nHA (B)
scaffolds. Ten micrograms of BMP was co-electrospun from HFP. Representative discs (n=6)
were incubated in PBS for a total of 2 weeks and released BMP detected by blotting onto
nitrocellulose membrane as described earlier. In spite of lack of an obvious trend, there are
no signs of initial burst release from either types of scaffolds
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scaffolds. There is no obvious initial burst, with the release peaking at 3 days for both
scaffold types and eventually tapering off to control levels.
6.3.5. Efficacy of BMP- 2/7 on C2C12BRA Luciferase Activity:
All types of BMPs, whether homo or hetero dimers, induced luciferase activity.
The response however was significantly higher when cells were cultured in the presence of
serum. The luciferase induction with BMP-2/7 heterodimer was much more potent than the
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Figure 30: Effects of BMP on C2C12 BRA cells cultured in the presence or absence of serum.
Cells were treated with different doses of BMP (0.1, 1, 10, 100 ng/ml) and luciferase activity
evaluated after 10 hours of incubation. The heterodimeric BMP-2/7 was the most potent BMP at
10 ng/ ml.
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corresponding homodimeric forms. The response observed with 10 ng/ml of BMP-2/7 was
the highest and exceeded even 100 ng/ ml dosage. This might probably be due to
overstimulation of cells and saturation of system (Figure 30). These data confirm that
C1C12BRA provide an excellent tool to study the effects of BMPs especially if cultured in
the presence of serum. BMP-2/7 showed at least a two fold increase in response at doses
that are five times less than BMP-2 or BMP-7. These indicate that the heterodimeric form
of BMP is much more potent than either of homodimers
6.3.6. Efficacy of Organic-Solvent Exposed BMP- 2/7 on C2C12BRA Luciferase
Activity:
As expected, of the BMPs not exposed to solvents, BMP-2/7 was the most potent.
BMP-2 and BMP-7 in buffer was identical in their ability to induce luciferase in
C1C12BRA cells. Exposure of either of the homodimers or the heterodimer to HFP or TFE
significantly reduced the luciferase activity. Of the two solvents tested, TFE seemed to
better restore the activity of BMP-2/7. BMP-2/7 exposed to HFP or TFE has significant
loss of biological activity, even though it was much higher than the homodimer controls
(Figure 31).
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Figure 31: Ef f ect of organic solvents on the biological activity of BMPs. Homodimer (BMP-2 and BMP-7) and
heterodimer (BMP-2/7) were exposed to an excess of organic solvents till the solvents completely evaporated. They
were then reconstituted in the solubilization buf f er and added to the C2C12BRA cells in culture. Af ter 10 hours
of incubation, cells were lysed and lucif erase activity detected.

More interesting was the effects of HFP and TFE diluted to 50% with aqueous
buffer. Not only does this step recover most of the activity of all types of BMP, but
achieves this without compromising the ability of the polymers to be electrospun. This is a
significant finding given the indispensability of organic solvents in electrospinning.
6.4. DISCUSSION
Growth factors need to be present in a critical concentration for a defined period of
time to be effective. BMPs, being water soluble, diffuse from the site of delivery and are
inactivated in extracellular fluid when delivered in a buffer [192]. To compensate for
losses, BMPs are administered at approximately 200,000 times the estimated physiologic
concentration [193].
114

Our hypothesis was that incorporation of BMP-2/7 during fabrication
(electrospinning) of scaffold will ensure their long term retention. In contrast, distribution
of BMPs will be restricted to the surface of the fibers if delivered as a buffer to an already
electrospun scaffold and will exhibit an initial burst release when placed in bulk media.
Since BMPs are allowed to interact with the polymer (PDO) prior to
electrospinning, we rationalize that this would incorporate the growth factor within the
scaffold much better. Addition of nHA to PDO is also expected to retain BMPs better
mainly due to interaction of BMP to nHA at an atomic scale prior to electrospinning. The
high surface energy of HA would also facilitate adsorption of BMPs [194, 195].
Additionally, electrospinning would incorporate BMPs at random within the individual
nanofiber and throughout the thickness of the scaffold. These entrapped BMPs will be
released into the media only after polymer degradation.
There are several explanations for the observations. First, there is a possibility of
favorable interaction between the BMP and polymeric nanofibers resulting in effective
incorporation and sequestration within the scaffold. In such a scenario, the BMP would be
released only upon fiber degradation which does not happen to PDO scaffolds to any
significant extent in 2 weeks. Thus two week duration might be too early for these studies.
On the other hand, amount of BMP-2/7 released from in the discs might be below
the detection limit of the slot-blotting technique. This argument does not hold well against
theoretical calculations that estimate the BMP content in the discs to be in the range of
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150- 300 ng. (The total surface area of the mandrel is 22.5 cm2). Since about 30% of the
polymer solution is typically lost during electrospinning, 7 µg of BMP-2/7 is dispersed
within the scaffold. This amount is well within the linear range of detection as described in
the standard curve earlier.
The third possibility is that the process of electrospinning can induce sufficient
denaturation of the peptide that the antibody can no longer recognize and bind. Even
though previous data shows good detection of BMPs following exposure to the solvent, the
effect of high voltage field on protein conformation is still not known. Denaturation of
proteins under electric field is quite possible and this part of electrospinning can be as
much of a problem to deal with as is the solvent. A simple experiment involving exposing
the BMPs to high voltage field followed by slot-blot will reveal the nature of interaction.
The slot-blot experiments showed no significant denaturation following exposure to
various solvents and near identical results with dilution of the solvent with buffer. While
this data was informative, all it means is that the denaturation (if any) was not sufficient
enough to prevent binding of the antibody to the epitope on the BMP-2/7 heterodimer. In
order to verify the possibility that no denaturation occurred, a biological test of retention of
function is necessary. Stably transfected C2C12BRA cells offered a great tool to
investigate and explore the retention of biological activity of the BMPs following exposure
to electrospinning solvents. If there were indeed no denaturation, all BMP-2/7 should
behave identical irrespective of the type of solvent to which it was exposed. Our results
from luciferase assay indicate significant loss of biological activity following exposure to
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organic solvents – HFP and TFE. Among these solvents, TFE ranked better. However, if
these solvents were made more polar by the addition of equal volume of aqueous buffer,
there is a complete recovery of the lost activity and the values are no different from the
controls.

6.5. CONCLUSION
We have successfully established a reliable slot-blot assay that enables specific
detection and quantification of BMP-2/7. Initial validation of BMP function and
optimization of dosage was done with C2C12BRA expressing luciferase in response to
BMP treatment. BMP-2/7 heterodimer was found to be at least 5 times more potent than
either of its homodimer counterparts, BMP-2 or BMP-7. We then coupled the slot-blotting
technique and the luciferase expression of C2C12BRA system to investigate the complex
questions concerning potential denaturing effects of organic solvents used in
electrospinning on BMP-2/7. Our results indicate significant reduction in the biological
activity of BMP-2/7 when exposed to an excess of solvent in the time duration relevant to
electrospinning. However, much if not all of the lost activity is restored if the organic
solvent is made more polar by dilution with aqueous buffer.
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Chapter 7: CONCLUSION AND FUTURE STUDIES:
Regenerative medicine and tissue engineering are rapidly growing scientific
disciplines that aim to restore structural, mechanical and metabolic functions of tissues and
organs that are dysfunctional or absent. In light of growing evidence of the role of
extracellular matrix in determining the form and function of the organ, synthesis of a
suitable ECM has been the goal of tissue engineering. Electrospinning is one of the most
commonly employed techniques in tissue engineering for the generation of nanoscaled
fibrous structures that can be exploited to mimic the native ECM with respect to its
composition and dimension.
The present study was devoted to developing synthetic bone substitutes intended
for cleft palate repair. Cleft palate is a congenital condition of bony deficiency in the
critical area of the mouth that significantly affects function and esthetics. Since well
documented disadvantages exist with autografts and allografts, a search for synthetic bone
analog is of substantial clinical relevance. In the present study, our first goal was to
synthesize a 3D porous nanofibrous scaffold as a composite containing inorganic nHA in a
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synthetic polymer matrix. This strategy would result in a better interface between the
constituent phases of the composite and result in improved material properties.
Accordingly, we devised a dual mineralization strategy wherein hydroxyapatite was
incorporated into the matrix during electrospinning as a first step. This was followed by
biomimetic mineralization of the electrospun scaffolds in SBF to further induce mineral
deposition. The amount of mineral deposited varies directly as a function of concentration
of inorganic nHA seeded during electrospinning.

Using multiple-factor interaction

statistics we concluded that PDO scaffolds containing 50% nHA incubated in r-SBF for 2
weeks resulted in maximum mineralization. Future studies can explore natural polymers
such as fibrinogen and chitin as scaffold materials. This would be of interest because
organized fibrin clot is slowly transformed into woven bone during natural fracture
healing. In this sense, fibrinogen may play a direct role in mineralization and osseous
healing. Chitin is another material that is not only abundant but also closely associated
with inorganic minerals in nature and may prove to be advantageous.
In an effort to further match the material properties of the synthetic bone scaffold to
the bone, we sought to exploit its natural plywood architecture. We attempted to mimic
bone by stacking multiple electrospun sheets on top of each other and used high pressure to
weld layers together. A pressure of 20,000 psi, held for a minute was sufficient in
successful welding of the layers without any evidence of de-lamination. In addition the
material properties of such multi-layered scaffolds greatly exceeded the values of single
layered electrospun scaffolds. On the other hand, the permeability of the multi-layered
scaffolds decreased as a function of the number of layers. Thus the strategy of biomimetic
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mineralization and cold welding multiple layers of electrospun scaffolds can effectively be
used to tailor the properties of the bone analog. Further investigation with respect to the
amount and duration of pressure application will reveal interesting insights into the
material behavior at the nanoscale.
In order to characterize the biological activity of the electrospun bone scaffolds, we
developed an osteoblast adhesion assay by quantifying vinculin that participates directly in
the focal adhesion complexes. In addition, a subset of vinculin - phosphovinculin (pY-822)
was identified as a reliable and quantifiable molecular marker of focal adhesions
irrespective of biomaterial surface studied. This seems to suggest that phosphorylation of
vinculin at (Y-822) as one of the potential mechanisms for the formation of focal adhesion
complexes. This specific form of vinculin was detected only when cells were grown on
surfaces that are conducive for cell adhesion. ICW assay for phosphovinculin, proposed in
this study, provides a simple yet accurate quantitative technique to follow the kinetics of
focal adhesion formation when traditional assays have proven difficult. The penetrative
ability of infrared rays further expands the scope of the assay to characterize
cytocompatibility of 3D tissue engineering scaffolds by their ability to induce cell adhesion
and migration.
Advances in recombinant technology and bone biology have established the potent
role of osteoinductive molecules (BMPs) and adoption of this concept to enhance bone
healing in tissue engineering has been quite seamless. However, this has been associated
with a lot of challenges in practice: mode of incorporation into the scaffold, preservation of
biological activity, ability to control and modulate release from the scaffold. One of the
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criticisms in their use in conjunction with electrospinning has been the potentially
denaturing interactions with the organic solvents. This study focuses on answering these
basic questions. Our data indicated that BMP-2/7 heterodimer was at least 5 times more
potent than either of its homodimer counterparts, BMP-2 or BMP-7 and hence was chosen
to study solvent interactions. A biologically relevant luciferase assay on C2C12BRA cell
lines was used to investigate potential loss of function of BMPs when exposed to organic
solvents used in electrospinning. Our results indicate significant reduction in the biological
activity of BMP-2/7 when exposed to an excess of solvent but most, if not all of the lost
activity can be restored if the organic solvent is made more polar by dilution with aqueous
buffer. This is a significant finding given the widespread popularity and use of organic
solvents in electrospinning. Reliable detection of distribution of BMP within the
electrospun matrix and optimization of its release is another area of tremendous challenge
and can form the basis of future studies.
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